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Abbreviations 
Bacterium names 
AOB:  Ammonia-oxidizing bacterium 
βAOB:   Beta-proteobacterial AOB  
NeAOB:   Nitrosomonas europaea NBRC 14298  (βAOB) 
NmAOB:   Nitrosomonas multiformis ATCC 25196 (βAOB) 
γAOB:   Gamma-proteobacterial AOB 
NoAOB:   Nitrosococcus oceani ATCC 19707  (γAOB) 
 
Protein names 
AMO:  Ammonia monooxygenase 
HAO:  Hydroxylamine oxidoreductase 
NeHAO:  HAO from NeAOB (βAOB) 
NmHAO:  HAO from NmAOB (βAOB) 
NoHAO:  HAO from NoAOB (γAOB) 
 
Technical terms of drug discovery 
BEI: Binding efficiency index {Inhibition activity (pIC50) / molecular mass (kDa)} 
IC50: The half maximal inhibitory concentration 
 (The concentration of an inhibitor that is required for 50% inhibition) 
pIC50:  −log10 (IC50) 
HTS: High-throughput screening 
SBDD: Structure-based drug design 
FBDD: Fragment-based drug design 
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RFU: Relative fluorescence unit 
S/B: Signal background ratio 
S/N: Signal noise ratio 
rmsd: Root-mean-square deviation 
SAR: Structure activity relationship 
 (Method for revealing effective chemical groups and chemical structures by 
determining IC50 value for target molecule and its analogs.)  
MOE: Molecular Operating Environment 
 (Software package for drug discovery, Chemical Computing Group Inc.) 
Contents 
3 
 
Contents 
 
Abbreviations................................................................................................................ 1 
Contents ....................................................................................................................... 3 
Figures........................................................................................................................... 6 
Tables ........................................................................................................................... 7 
Abstract ........................................................................................................................ 8 
General Introduction .................................................................................................. 10 
Effect of human-induced nitrogen flow to global nitrogen cycle .............................. 10 
Nitrification .................................................................................................................. 10 
Nitrification inhibitor .................................................................................................. 13 
Nitrification inhibitor discovery innovated by using latest drug design techniques of 
medicine ........................................................................................................................ 14 
Nitrification pathway; potential target of nitrification inhibitors ........................... 15 
 
Chapter 1 Establishment of the experimental technology for nitrification inhibitor 
development ............................................................................................................... 20 
Introduction ..................................................................................................................... 20 
Materials and methods ................................................................................................... 20 
Culture media .............................................................................................................. 20 
Cell lines and cell cultures .......................................................................................... 21 
Nitrification activity assay for AOB cells ................................................................... 22 
Purification of HAO ..................................................................................................... 22 
Characterizations of purified proteins ....................................................................... 23 
Optimization for HAO colorimetric activity assay using cytochrome-c ................... 24 
Crystallization for NeHAO.......................................................................................... 25 
Crystallization for NoHAO.......................................................................................... 26 
Data collection and structure analysis for NeHAO and NoHAO ............................. 26 
Results and discussion .................................................................................................... 27 
Mass culture systems for AOB strains. ...................................................................... 27 
High-throughput nitrification assay using live AOB cell ......................................... 27 
Purification of NeHAO and NoHAO by newly developed simplified methods ........ 28 
Optimization of middle-throughput HAO “COLORIMETRIC” assay ..................... 32 
Newly developed HAO “FLUORESCENCE” assay method ..................................... 34 
Structure analysis for NeHAO and NoHAO .............................................................. 41 
Contents 
4 
 
Conclusion ........................................................................................................................ 43 
 
Chapter 2 Re-profiling for known nitrification inhibitors ............................................ 45 
Introduction ..................................................................................................................... 45 
Materials and methods ................................................................................................... 46 
Nitrification activity assay .......................................................................................... 46 
Compounds ................................................................................................................... 46 
Results and discussion .................................................................................................... 46 
 
Chapter 3 Comparative analysis of inhibitor response and crystal structure for HAO 51 
Abstract ............................................................................................................................ 51 
Introduction ..................................................................................................................... 51 
Materials and methods ................................................................................................... 52 
Determine IC50 for nitrification activity of AOB cell ................................................. 52 
Determine IC50 for HAO inhibitor .............................................................................. 52 
Structure analysis for complexes of NoHAO-acetaldoxime and NoHAO-
phenylhydrazine .......................................................................................................... 52 
Homology modeling ..................................................................................................... 53 
Results .............................................................................................................................. 53 
Comparison of inhibitory response between NeHAO of βAOB and NoHAO of γAOB
 ....................................................................................................................................... 53 
Comparison of crystal structures of NeHAO and NoHAO ....................................... 55 
Comparison of active center of HAOs......................................................................... 59 
Discussion ........................................................................................................................ 61 
 
Chapter 4 HAO inhibitor screening ............................................................................ 66 
Introduction ..................................................................................................................... 66 
Materials and methods ................................................................................................... 66 
Analysis for HAO-inhibitor complex structure .......................................................... 66 
Docking model of HAO-benzaldoxime ........................................................................ 66 
In-silico screening ........................................................................................................ 66 
Nitrification activity assay .......................................................................................... 67 
Structure analysis for complex of NoHAO-benzaldoxime ........................................ 67 
Results and discussion .................................................................................................... 67 
Screening seed compounds by using crystal soaking and structure analysis ......... 67 
Designing chimera compound by linking of two inhibitors by using fragment based 
Figures 
6 
 
Figures 
Figure 1. Major transformation of natural nitrogen cycle in soil. ............................................... 11 
Figure 2. Nitrification of applied nitrogen fertilizer. ................................................................... 12 
Figure 3. Nitrification pathway in AOB. ..................................................................................... 16 
Figure 4. Ammonia monooxigenase (AMO) modeled structure. ................................................ 17 
Figure 5. NeHAO structure. ........................................................................................................ 18 
Figure 6. Integrated purification method for NeHAO................................................................. 30 
Figure 7. Integrated purification method for NoHAO. ............................................................... 31 
Figure 8. Optimization of HAO “COLORIMETRIC” assay using cytochrome-c. ..................... 33 
Figure 9. Measurement principle of HAO fluorescence assay. ................................................... 36 
Figure 10. Excitation-emission profile for HAO fluorescence assay. ......................................... 37 
Figure 11. pH dependent fluorescent intensity difference for HAO fluorescence assay and 
resorufin. ............................................................................................................................. 38 
Figure 12. Ratio of hydroxyalamine and resazurin affects signal background ratio on HAO 
fluorescence assay. .............................................................................................................. 39 
Figure 13. Validation for HAO fluorescence assay. .................................................................... 39 
Figure 14. Additives check on HAO fluorescence assay............................................................. 40 
Figure 15. DMSO dependent activity of NeHAO fluorescence assay. ....................................... 40 
Figure 16. Crystals of NeHAO and NoHAO. ............................................................................. 42 
Figure 17. X-ray crystal structure of Nitrosococcus oceani HAO (NoHAO). ............................ 42 
Figure 18. Heme P460 in NoHAO was linked to the Tyrosine. .................................................. 43 
Figure 19. Nitrification activity assay procedure. ....................................................................... 47 
Figure 20. Re-profiling for 38 known nitrification inhibitors. .................................................... 49 
Figure 21. Sorted graph for IC50 of known nitrification inhibitors. ............................................ 50 
Figure 22. Comparison for SDS-PAGE and Uv–vis spectra of purified NeHAO and NoHAO.. 54 
Figure 23. Difference of inhibitory responses of HAOs for phenylhydrazine. ........................... 55 
Figure 24. Comparison of NeHAO and NoHAO. ....................................................................... 57 
Figure 25. Relative arrangement of entrance side of the ligand binding pocket on the NeHAO, 
NoHAO and Kustc1061. ..................................................................................................... 58 
Figure 26. Comparison for active centers of NeHAO with other HAOs. ................................... 60 
Figure 27. Structure-guided multiple protein alignment of HAOs from AOB, comammox and 
anammox. ............................................................................................................................ 64 
Figure 28. Screening procedure for HAO inhibitor by crystal soaking and structure analysis. .. 68 
Figure 29. NoHAO-substrate mimic complex structures. ........................................................... 69 
Figure 30. Benzaldoxime designed by fragment-based drug design (FBDD) approach. ............ 70 
Abstract 
8 
 
Abstract 
Anthropogenic nitrogen input to global nitrogen cycle as a fertilizer affects the sustainability in 
agriculture and the health of the earth’s environment. Ammonia-oxidizing bacteria (AOB), ubiquitous 
chemoautotrophic bacteria, cause nitrification of ammonium-fertilizers that is involved in nitrogen 
run-off and greenhouse gas nitrous oxide (N2O) emission in agricultural land. Nitrification inhibitors, 
AOB specific bactericides, are widely used for prevention of nitrification. However, new nitrification 
inhibitors are desired because of toxicity and weak-effects of currently used inhibitors. 
 In this study, I have developed lead compounds of new nitrification inhibitor targeting to 
hydroxylamine oxidoreductase (HAO), a key enzyme of nitrification that catalyzes hydroxylamine to 
nitrite. Since a lot of uncultured AOB species have been discovered from soil by metagenomic analysis, 
the new nitrification inhibitor with wide-spectrum must be developed. For this purpose, I used two 
HAOs, NeHAO from Nitrosomonas europaea and NoHAO from Nitrosococcus oceani, which were 
phylogenetically distant from each other. My scheme utilizes combined use of X-ray crystal structure 
analysis, pharmacophore search, fluorescent HAO activity assay, cell-based nitrification assay, and 
structure-activity relationship (SAR) analysis.  
I first solved the crystal structure of NoHAO, and then screened inhibitor seeds by soaking 
of substrate-mimicking hydroxylamine and hydrazine derivatives. An oxime compound and 
phenylhydrazine, a well-known HAO inhibitor, were bounded to the active center of HAO in the 
crystal structure. After setting HAO-inhibitor fragments of these compounds as pharmacophores, I 
performed pharmacophore search against a virtual library of 5 million commercial compounds 
(supplied by Namiki shoji) by using MOE software. The search provided approximately 100 hit-
compounds. 
 In parallel, I developed a fluorescent HAO activity assay that can be applied to high-
throughput screening on a 384-well plate. Using this assay, I analyzed inhibition activities of 77 out 
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General Introduction 
  
Effect of human-induced nitrogen flow to global nitrogen cycle 
In agriculture, nitrogen, phosphorus and potassium (N-P-K) are called ‘the Big 3’ primary nutrients 
that play fundamental roles in fertilizer for crop growing. However, available supplies of the three 
resources are different from one to another. Phosphorus and potassium are limited source which are 
supplied only by mining from rock resources. On the other hand, nitrogen can be supplied as industrial 
ammonium, which is synthesized using Haber-Bosh process from nitrogen molecule (N2) in air. 
Therefore, nitrogen fertilizer is applied to farm-land excessively. Nitrogen fertilizer use has increased 
explosively since the 1950s due to appearance of the industrial inexpensive nitrogen fertilizer, and is  
substituted from rotation growth of food crop and forage legumes such as alfalfa, red clover, and sweet 
clover [1]. A large amount of the human applied nitrogen fertilizer affects nitrogen flows of the earth’s 
biogeochemical cycles. Total nitrogen input was ~136.60 trillion grams (Tg) (= Mega ton) of nitrogen 
per year in the year 2000 [2]. Almost half of the nitrogen input was industrial fixed nitrogen fertilizer, 
such as anhydrous ammonium, ammonium sulfate, urea. 16 % of nitrogen input is from biofixation by 
microorganisms, such as rhizobium in root nodules of leguminous plants. Manure, recycled crop 
residues, and atmospheric deposition are contributed with each 8–13% of nitrogen input [2]. The large 
amount of human applied nitrogen has a significantly negative effect on the sustainability of 
agriculture, health of earth’s environment, and human health [3]. 
 
Nitrification 
Nitrogen is changing chemical forms in natural nitrogen cycle on soil (Figure 1) [3–5]. Under natural 
conditions, soil organic matters, which consists remains of living organisms, release ammonium 
(NH4
+) by proteolysis and ammonification of soil microorganisms. The NH4
+ is oxidized to nitrite 
(NO2
−) by ammonium-oxidizing bacteria (AOB), and the nitrite (NO2
−) is further oxidized to nitrate 
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(NO3
−) by nitrite-oxidizing bacteria (NOB). The biological oxidation of NH4
+ to NO3
− is called 
“nitrification” [6].  The mineral nitrogen chemicals (NH4
+ and NO3
−) are immobilized (taken up and 
converted) to organic nitrogen, such as amino acid, by plants. 
 
 
 
Figure 1. Major transformation of natural nitrogen cycle in soil. 
Organic materials, such as plants, are decomposed by mainly 
heterotrophic microorganisms, and release ammonium (NH4+) 
(ammonification). The NH4+ is oxidized to nitrite (NO2−) by ammonium-
oxidizing bacteria (AOB), and then the NO2− is oxidized to nitrate (NO3−) 
by nitrite-oxidizing bacteria (NOB) (nitrification). The NH4+ and NO3− 
are immobilized as organic nitrogen through assimilation by plants. 
(The figure is modified from Haynes et al. [4] ) 
 
 In farm-lands, excessive nitrogen fertilizers were applied and affected to nitrogen cycle 
(Figure 2). Nearly 90% of the applied nitrogen is in the NH4
+ form [7]. Excessive application of the 
NH4
+ leads to overgrowth of AOB and NOB. Then, the NH4
+ is converted to NO3
− by nitrification of 
AOB and NOB, mostly within four weeks after application [7]. The nitrification decreases nitrogen-
use efficiency (NEU) by leaching of NO3
− to surrounding waterbodies, such as underground water, 
river, lake, and sea. It has been estimated that a nearly 70% of applied nitrogen is lost from farm-land 
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[3]. The nitrogen leaching is caused by the difference in ionic mobility of NH4
+ and NO3
− in most soils. 
Because clay surface sand and soil organic matters are charged negatively, positively charged NH4
+ 
can be binding to soil strongly by electrostatic forces. On the other hand, negatively charged NO3− 
makes very few interactions with the soil, and has high mobility (diffusion coefficient ~ 10−6 cm2 s−1). 
It is suggested that the mobility of NO3− in soil is 50–500-fold higher than that of NH4
+ [5]. Therefore, 
NO3− easily run off from farm-land during rains. Especially, in artificial drain system equipped farm-
lands often on the middle to high-clay soil (e.g. in the upper Midwest Corn Belt of the United States), 
nitrogen leaching is very high [2]. The inversion of charge is caused by the nitrification of AOB. 
Therefore, control of nitrification rate is very important to decrease nitrogen runoff. 
 
Figure 2. Nitrification of applied nitrogen fertilizer. 
A large amount of ammonium (NH4+) synthesized by industrial nitrogen 
fixation was applied to farm-land as nitrogen fertilizer. A portion of the 
ammonium is uptaken directly by crops, however, most of the 
ammonium is metabolized to nitrite (NO2−) and byproduct of nitrous 
oxide (N2O) gas (Greenhouse gas) by AOB. NO2− is subsequently 
metabolized to nitrate (NO3−) by nitrite oxidizing-bacteria (NOB, not 
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shown). NO3− accumulated to farm-land is uptaken slowly by crops. 
However, the NO3− is easily washed out from farm-land by rain fall. The 
charge of nitrogen compound is inverted from positive to negative by 
AOB metabolize. It is difficult for negatively charged soil to hold the 
negatively charged NO3−. The leaked NO3− cause eutrophication of 
water-bodies (river, lake, sea, under-ground water) and pollution of 
drinking water. 
 
The unnatural nitrogen cycle caused by the large amount of human applied nitrogen leads to 
significantly negative effects to environment [3]. The three most important negative effects are 
eutrophication/pollution of water bodies, greenhouse gas emission, and energy loss associated with 
synthesizing of nitrogen fertilizer. Firstly, the eutrophication of water body is caused by leaching of 
NO3−, which promotes growth of cyanobacteria and phytoplankton. As a typical case, 
eutrophication and bottom-water hypoxia of northern Gulf of Mexico were caused by nitrogen 
leaching from fertilized corn fields around Mississippi river in U.S. [8]. Furthermore, pollution of 
NO3− to water-source of tap water leads to health risks that includes methemoglobinemia, which 
causes cyanosis, to human (“Blue Baby syndrome”) [9] and live stocks [3]. Secondly, N2O, 
a greenhouse gas 296 times stronger than CO2, is proceeded during nitrification of AOB 
[3].  Furthermore, greenhouse gasses are also produced in the process of synthesizing 
nitrogen fertilizer. Thirdly, industrial nitrogen fixation process requires a large amount 
of energy (13,800 kcal kg−1 N fixed) [3] obtained by burning fossil fuels, and also leads to 
CO2 emission. To decrease these negative effects, nitrification control technologies includes 
nitrification inhibitors are used. 
 
Nitrification inhibitor 
Nitrification inhibitor is a specific bactericide to AOB for controlling nitrification activity and is 
applied to farm-land with fertilizer. A number of nitrification inhibitors have been developed; 60 
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compounds including 20 commercially available nitrification inhibitors have been reported [3,10–18]. 
Typical studies have shown that commercial nitrification inhibitors decreased 63% of nitrogen 
leaching [19] and 38% of N2O emissions [18], and have a lot of other advantages both environmentally 
and economically [3,18,20] (Table 1A). On the other hand, commercial nitrification inhibitors possess 
particular problems such as toxicity and weak effects (Table 1B). Thus, next-generation nitrification 
inhibitors are demanded. Since inhibition mechanisms of commercially available nitrification 
inhibitors have not been determined, the rational modification of the inhibitors to improve inhibition 
activity is difficult. Therefore, new methodology for nitrification inhibitor design is needed. 
 
Table 1. Advantages (A) and disadvantages (B) of conventional 
nitrification inhibitors. 
 
Nitrification inhibitor discovery innovated by using latest drug design techniques of 
medicine 
For designing new and effective nitrification inhibitor in this study, I have tried to introduce latest drug 
design techniques for medicinal chemistry, such as high-throughput inhibitor screening and evaluation 
assay, structure-activity relationship (SAR) analysis, and structure-based drug design (SBDD) method 
A. Advantages of using nitrification inhibitors 
 Reduce applied nitrogen fertilizer. 
 Reduction of labor by decreasing rate of fertilizer application. 
 Increase crop production. 
 Decrease N2O gas emission (Greenhouse and ozone layer destruction gas). 
 Decrease eutrophication of river, lake, and sea. 
 
B. Disadvantages of conventional nitrification inhibitors 
 Toxicity/Oncogenesity 
 Volatilized at more than 20 °C (Nitrapyrin) 
 Low nitrification inhibition effect 
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including fragment based drug design (FBDD) method and structure based in-silico screening [21]. 
Especially, SBDD is a prominent component of modern medicinal chemistry [22–24]. SBDD method 
uses three-dimensional structural information of the drug target enzyme to visualize the shape of ligand 
binding pocket for designing molecules fitting into the pocket. On the other hand, no agrochemicals 
developed by SBDD have been launched so far, and have never applied to nitrification inhibitor design. 
To perform SBDD, highly purified sample and experimentally determined structure information of 
target protein are needed. I have selected for the target protein from key enzymes of nitrification 
pathway in AOB. 
 
Nitrification pathway; potential target of nitrification inhibitors 
In AOB, ammonia monooxygenase (AMO) and hydroxylamine oxidoreductase (HAO) are key 
enzymes of nitrification pathway, and catalyze ammonia (NH3) to nitrate (NO2
−) via hydroxylamine 
(NH2OH) by following chemical reactions [25]: 
 
AMO:  NH3 + 2H
+ + O2 + 2e
−  →  NH2OH + H2O,
 
HAO:  NH2OH + H2O  →  NO2
− + 5H+ + 4e−. 
 
In this pathway, four electrons are generated by HAO; two electrons are transferred back to AMO as 
the catalytic energy source, and the remaining two electrons are consumed as a growth energy through 
generating NADPH and ATP [26] (Figure 3). 
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Figure 3. Nitrification pathway in AOB. 
Ammonium (NH4+) is first oxidized to hydroxylamine (NH2OH) by 
ammonia monooxigenase (AMO) using two electrons (e−). The 
hydroxylamine oxidized to nitrite (NO2−) by hydroxylamine 
oxidoreductase (HAO), and four electrons are released by the reaction. 
The electrons are transferred to cytochrome c554. Then, two electrons 
are returned back to AMO, and the remaining electrons are ultimately 
transferred to the terminal oxidases and used for the growth energy. 
The N2O is possibly generated by HAO as a byproduct. The N2O pathway 
has not been fully characterized and alternative routes are believed to 
exist [27]. 
 
Therefore, both of the enzymes, AMO and HAO, are potential targets of nitrification inhibitors. 
Actually, AMO is believed to be a molecular target of commercial nitrification inhibitors such as 
nitrapyrin [28]. However, rational design of AMO-targeting inhibitor is difficult. AMO is believed to 
be a membrane protein that assembled trimer-of-trimer structure including three subunits: AmoA, 
AmoB, AmoC (Figure 4). In general, analysis of membrane proteins forming a large complex is very 
difficult. Actually, purification of AMO has not been succeeded over more than 50 years. So, valuable 
in vitro assay methods and experimental three-dimension structure (e.g. crystal structure) information 
of AMO are not available yet.  
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Figure 4. Ammonia monooxigenase (AMO) modeled structure. 
(A) Whole structure of AMO that forms 9mer (trimer-of-trimer) 
structure includes each three AmoA, AmoB and AmoC subunits. (B) 
Trimer subunit structure of AMO. (C) monomer structure of AmoA, 
AmoB and AmoC subunits. The structures were modeled by I-tasser 
server [29] separately for each subunit that amino acid sequences are 
used with: AmoA (UniProt KB entry, AmoA1_NITEU), AmoB 
(AmoB1_NITEU), AmoC (AmoC2_NITEU). Assemble to 9-mer form was 
performed by PyMOL software using the methane monooxigenase 
structure (pMMO, PDB:1YEW) from Methylococcus capsulatus (methane 
oxidizing-bacteria) as a template. 
 
HAO is a newly-emerging target of nitrification inhibitor. Recently, Wu et al. [30] have 
reported that the activity of soil nitrification was suppressed by organo-hydrazines that act as suicide 
inhibitors for HAO [31]. Crystal structures of naturally purified βAOB Nitrosomonas europaea HAO 
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(NeHAO) have been resolved [32–34], and they allow us to develop HAO inhibitors by structure-
guided drug design. Therefore, I believed that HAO is more suitable as a nitrification-inhibitor target 
than AMO. 
HAO is soluble trimer protein including total 21 heme-c and 3 heme P460 (Figure 5). The 
heme P460 is covalently connected to tyrosine that inserted from next subunit. So, each subunits of 
trimer were covalently connected. The active center was located on the heme P460 in the ligand 
binding pocket. If you could design to block the pocket, the hydroxylamine oxidoreductase reaction 
will be stop. This is the main reason why we have selected HAO as a target of inhibitor.  
 
 
Figure 5. NeHAO structure. 
Overall (left) and close up (right) view of trimer complex of NeHAO. Two 
subunits are represented in surface model (brown and light blue), one 
subunit is represented in cartoon model (grey) on left panel. Covalent 
bonded tyrosine side chain is shown in blue. Heme P460 and heme-c 
were colored red and pink, respectively. Conserved amino acid side 
chains in active center are shown in stick models colored in green. 
Structure representations were prepared by PyMOL. 
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Here, I show nitrification inhibitor discovery strategy adapted cutting edge medicinal drug discovery 
technologies and obtained effective lead compounds. My results will assist developing effective next-
generation nitrification inhibitors, and will lead to promotion of sustainable agriculture.
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Chapter 1 
Establishment of the experimental 
technology for nitrification 
inhibitor development 
Introduction 
I first established fundamental methods that required for nitrification inhibitor development study; 
integrated preparation systems for HAO, high-resolution three-dimensional structural information for 
NeHAO and NoHAO, high-throughput inhibition assay systems for live AOB cell (colorimetric) and 
purified HAO (colorimetric and fluorescence). 
 
Materials and methods 
Culture media 
The culture medium “NeMedium ver. 2014.12” modified for Nitrosomonas europaea, Nitrosomonas 
sp. JPCCT2, Nitrosospira. multiformis, and Nitrosospira lacus was prepared by slightly modifying 
NBRC Medium 829 [35] and the previous report [36]. The 1 L medium included 11.29 g HEPES 
(Sigma-Aldrich, St. Louis, MO, USA), 2.5 g ammonium sulfate, 40 mg Fe(III)-EDTA (Dojindo 
laboratories, Kumamoto, Japan), 0.5 g KH2PO4, 0.5 g NaHCO3, 0.5 g MgSO4·7H2O, 100 mg 
CaCl2·2H2O, 0.001% (w/v) phenol red, 1 mL of 1000× trace-element mixture. Stock solution of the 1 
L 1000× trace-element mixture included 30 mg H3BO3, 100 mg MnCl2·4H2O, 190 mg CoCl2·6H2O, 
24 mg NiCl2·6H2O, 2 mg CuCl2·2H2O, 144 mg ZnSO4·7H2O, 36 mg Na2MoO4·2H2O and 8 mL of 
12N HCl. The chemicals were dissolved in deionized water. The media was adjusted to pH 7.9 (25 °C) 
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with 10N NaOH. The 20 L media was autoclaved in the 20-L plastic carboy (Nalgene® Round 
Polycarbonate Clearboy® with Spigot, Thermo Fisher Scientific, Waltham, MA, USA).  
The culture medium “NoMedium ver. 2014.12“ for Nitrosococcus oceani was prepared 
according to previous reports [36,37] with slightly modification. The 1 L medium was prepared for 
990-ml mother solution and 10 ml-metal solution, separately. The 990 mL mother solution included 
10.46 g MOPS (Sigma-Aldrich), 2.5 g ammonium sulfate, 27.5 g NaCl, 15 mg KH2PO4, 0.2 g NaHCO3, 
6.78 g MgSO4·7H2O, 5.38 g MgCl2·6H2O, 0.72 g KCl, 0.001% (w/v) phenol red. The mother solution 
was adjusted to pH 7.9 (25 °C) with 10N NaOH. The 10-mL of metals solution included 100 mg 
CaCl2·2H2O, 4 mg Fe(III)-EDTA, 1 mL of 1000× trace-element solution. For making 20-L medium, 
19.8-L mother solution was autoclaved in the 20-L plastic carboy, and then the 200-mL metals solution 
was added to the mother solution, aseptically. Unless otherwise specified, highest grade available 
chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan) or Nacalai Tesque 
(Kyoto, Japan).  
 
Cell lines and cell cultures 
N. europaea strain NBRC 14298 (=ATCC 19718) (NeAOB) and Nitrosomonas sp. NBRC 108559 
(=JPCCT2) were purchased from National Institute of Technology and Evaluation, Biological 
Resource Center (NBRC) (Chiba, Japan). N. oceani ATCC 19707 (NoAOB), N. multiformis ATCC 
25196 (NmAOB) and N. lacus ATCC BAA2542 (=APG3) were purchased from ATCC (Manassas, 
Virginia, USA). Stocked culture stored at 4 °C was inoculated to 40 mL medium, and incubated for 1 
week at 26 °C with gently shaking (~80 rpm). Then, the pre-culture was inoculated to the 20 L medium 
in a 20-L plastic carboy (Nalgene® Round Polycarbonate Clearboy® with Spigot, Thermo Fisher 
Scientific, Waltham, MA, USA), and was incubated for 2 weeks at room temperature (25 °C) with air 
ventilation (2.5 L/min) until phenol red turned to yellow (pH ~6.0). For the use of purification of HAO, 
the cells were harvested by centrifuge with 7000 × g, and were stored at −80 °C until purification. For 
Chapter 1 
Establishment of the experimental technology for nitrification inhibitor development 
22 
 
the use of live cell inhibitor assay, the culture is stored at 4 °C and used within 2 weeks. The yields of 
the each AOB strain cells were approximately 1.5 g by 20-L cultures. 
 
Nitrification activity assay for AOB cells 
AOB cells transferred to same volume of fresh medium were divided into 100 μL to each wells of 384 
deep well plate (BIO-BIK, Osaka, Japan). 0.5 μL DMSO solutions containing certain concentration 
of phenylhydrazine were added to each wells. The plate was sealed with air-exchange film (AeraSeal™, 
EXCEL Scientific, Victorville, CA, USA), and incubated for 18 hours at 25 °C. Then, 1 μL of the 
media in each wells were transferred to 384-well non-binding clear microplate (Greiner) filled with 
100 μL Greiss Reagent in each wells. After 20 min incubation at room temperature (25 °C), 545 nm 
absorbance was measured by using Infinite® M1000 PRO microplate reader (Tecan). The Greiss 
Reagent was optimized to be composed of same volumes of stock solution A {2% (w/w) sulfanilamide, 
12% (v/v) phosphoric acid} and stock solution B {0.2% (w/w) N-(1-naphthyl)ethylenediamine} 
according to Giustarini et al. [38] with slight modifications. The stock solutions A and B were stored 
at 4 °C, and mixed just before measurements. The half-maximal inhibition concentration (IC50) was 
calculated by GraphPad Prism6 software (GraphPad Software, La Jolla, CA, USA). 
 
 
Purification of HAO 
Frozen cell pellet (~1.5 g) was suspended in 40 mL buffer A (pH 7.5, 50 mM Tris-HCl) and sonicated. 
The suspension was then centrifuged at 40 000 × g for 40 min at 4 °C. The supernatant was applied to 
an anion-exchange column system composed of three tandemly connected HiTrap™ Q HP 5 mL 
columns (GE Healthcare, Buckinghamshire, England, UK), which were equilibrated with buffer A. A 
linear gradient of NaCl was performed with 0–500 mM NaCl in 100 mL buffer A. Post-elution cleaning 
was performed using 1 M NaCl. The eluted HAO fractions were subsequently applied to a HiLoad™ 
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26/600 Superdex™ 200 pg gel-filtration column (GE Healthcare) equilibrated with buffer B (pH 7.5, 
10 mM Tris–HCl, 150 mM NaCl). Then, the eluted HAO fractions were applied to hydroxyapatite 
column composed of 5 mL CHT™ Ceramic Hydroxyapatite media (Type 1, 20 μm particle size, Bio-
Rad, Hercules, CA, USA) packed to 10 mm inner diameter column that was equilibrated with buffer 
C (pH 7.5, 20 mM potassium phosphate buffer). The elusion was performed by linear gradient of 20–
500 mM potassium-phosphate buffer (pH 7.5). This hydroxyapatite chromatography step is not 
necessary for purification of NoHAO. Thereafter, the eluted HAO fractions were applied to a high-
performance anion-exchange column Mono Q® 10/100 GL (GE Healthcare). The elution was 
performed using a linear gradient of NaCl in buffer A (0–500 mM, 100 mL). Post-elution cleaning was 
performed using 1 M NaCl. The eluted HAO fractions were then stored at 4 °C until further 
experiments.  
All chromatography procedures were performed using the ÄKTAexplore 100 system (GE 
Healthcare). All eluted fractions containing HAO were detected by two methods: 1) wavelength 
monitoring by ÄKTAexplore (protein: 280 nm; c-type hemes in HAO: 409 nm) and 2) SDS-PAGE 
analysis with coomassie brilliant blue stain. 
 
Characterizations of purified proteins 
N-terminal sequences of the purified proteins were analyzed by Procice® 491HT Protein Sequencing 
System (Applied Biosystems, Foster, CA, USA). Crystallization of NeHAO was performed as 
described by Maalcke et al. [34]. Protein concentration was determined by Qubit® protein assay kit 
(Thermo Fisher Scientific) with Quick Start® Bovine Serum Albumin Standard Set (Bio-Rad, Hercules, 
CA, USA). The UV–vis spectra were measured from 220 to 800 nm with 0.2 nm bandwidth and 0.1 
nm s−1 scan rate at 25 °C using a Cary 400 Bio spectrophotometer (Varian, Zug, Switzerland). The 
measurement buffer was 20 mM Tris-HCl with or without 50 mM dithionite. The dithionite was 
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prepared as a 1 M solution, and was added to the protein solution immediately before measurement. 
Tris-Glycine-SDS-PAGE was performed on 5–20% gradient polyacrylamide precast-gel (e-PAGEL® 
E-R520L, ATTO, Tokyo, Japan) with EzRunC+ electrophoresis buffer (ATTO). To detect low 
molecular mass proteins, Tris-Tricine-SDS-PAGE was performed on 15% polyacrylamide precast-gel 
(e-PAGEL® E-R15S, ATTO) with the electrophoresis buffer containing 100 mM Tris, 50 mM Tricine, 
and 0.1% (w/v) SDS. The samples were boiled at 100 °C for 3 min with same volume of the Laemmli 
sample buffer composed of 125 mM Tris-HCl, 0.004% (w/v) bromophenol blue, 4% (w/v) SDS, 20% 
(w/v) glycerol, 10 mg/mL dithiothreitol (DTT), pH 6.8. The sample buffer was stocked in a −20 °C 
freezer in single-use volumes because air oxidization of DTT leads to diffusion of the HAO bands. 
The boiled samples in 10 μL were applied to the gel. BenchMark™ Protein Ladder (Thermo Fisher 
Scientific) was used as a protein marker. The gel was stained by coomassie brilliant blue solution 
EzStain AQua (ATTO). 
 
Optimization for HAO colorimetric activity assay using cytochrome-c 
HAO activity assay was performed based on the procedure reported by Logan et al, which was a 
method detecting HAO activity by increase of 550 nm absorbance of reduced cytochrome-c coupled 
with hydroxylamine oxidation by HAO [39]. 100 μL reaction mixture for one assay contained 50 μM 
hydroxylamine, 50 μM horse-heart cytochrome-c (Nacalai Tesque), several buffer types, pH, NaCl 
concentration, and additives. The reaction was started by addition of hydroxylamine. The absorbance 
was measured by using Infinite® M1000 PRO microplate reader (Tecan) on a 384-well non-binding 
clear microplate (Greiner bio-one, Kremsmünster, Austria). The reactions were performed at room 
temperature (25 °C). The relative activity was calculated by defining highest absorbance after 
incubation as 100% and initial absorbance as 0%. Optimization for pH and buffer was performed for 
using following conditions; 20 mM citric acid buffer (pH 2.57, 2.27, 3.00, 3.16, 3.37, 3.60, 3.80, 4.06, 
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Wako), 20 mM citrate-phosphate buffer (pH 3.16, 3.38, 3.57, 3.67, 3.78, 4.02, 4.25, 4.66, 4.76, 4.91, 
5.16, 5.35, 5.59 ,5.80, 5.90 ,6.00, 6.18, 6.35, 6.65, 6.66, 6.77, 6.85, 7.02 ,7.19, 7.33 ,7.48, 7.53, Wako), 
potassium-phosphate buffer (pH 5.55, 5.77, 5.94, 5.99, 6.08, 6.24, 6.39, 6.53, 6.65, 6.72, 6.81, 6.96, 
7.09, 7.22, 7.37, 7.46, 7.52, 7.69, 7.83, 7.94, 8.05, 8.08, 8.11, 8.12, Wako), HEPES-NaOH buffer (pH 
6.55, 6.75, 6.95, 7.12, 7.22, 7.31, 7.53, 7.75, 7.88, 8.07, Sigma-Aldrich), 20 mM Tris-HCl buffer (pH 
6.78, 6.96, 7.34, 7.51, 7.57, 7.66, 7.84, 7.89, 8.14, 8.25, 8.35, 8.39, 8.47, 8.57, 8.65, Nacalai Tesque), 
CAPSO buffer (pH 8.98, 9.26, 9.47, 9.63, 9.82; Hampton research), CAPS buffer (pH 10.11, 10.21, 
10.32, 10.55, 10.75, 10.83; Hampton research), n = 4, total 384 assays. Optimization for salt 
concentration was performed by NaCl varied with 0, 12.5, 25, 50, 100, 200, and 400 mM in 50 mM 
HEPES-NaOH (pH 7.0) buffer. HAO assay validation and inhibition assays were performed with 100 
μL solution containing 50 mM HEPES-NaOH (pH7.0), 50 mM NaCl, 50 μM hydroxylamine, 50 μM 
horse heart cytochrome-c, 0.01% Triton X-100, and 0.5 μL DMSO in which certain concentration of 
phenylhydrazine was dissolved. 
 
Crystallization for NeHAO 
NeHAO was crystallized as described by Cedervall et al. [33,40] and Maalcke et al. [34]. In brief, 
stocked HAO solution was dialyzed with buffer C (pH 7.5, 25 mM HEPES-KOH, 25 mM KCl), and 
was concentrated to 5 mg/mL using VIVASPIN® concentrator (0.5 mL, 10,000 MWCO PES, 
Vivascience, Hannover, Germany). Under oil batch crystallization was performed on oval plates 
(Nunc® MiniTrays with Nunclon® Delta surface, 60-well, Thermo Fisher Scientific) using 2 μL of 
protein solution and 2 μL mother solution containing 42 % (v/v) PEG400 (Hampton Research, Aliso 
Viejo, CA, USA), 50 mM KNO3 (Wako), MES (Wako) /NaOH buffer (pH 7.5) under thin layer of 10 
μL Al’s oil (Hampton Research). The crystals grew to more than 0.4 mm within 2 weeks. 
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Crystallization for NoHAO 
Preliminary screening of crystallization conditions for NoHAO was performed by the sitting-drop 
vapor-diffusion method at 20 °C using Crystal Screen HT, Crystal Screen Cryo HT (Hampton 
Research) and Wizard JCSG+ (Emerald BioSystems). Drops containing 0.3 μL protein solution in 20 
mM Tris-HCl buffer, pH 7.5, and 0.3 μL mother liquor were equilibrated against 50 μL reservoir 
solution. Tiny crystals of NoHAO were observed under several conditions with 2.4–2.8 M ammonium 
sulfate within a week. Further optimization of ammonium sulfate concentration, pH and buffer 
solution was carried out by the hanging-drop vapor-diffusion method with 8 μL protein solution with 
a concentration of 5 mg ml-1, 8 μL mother liquor and 500 μL reservoir solution. Finally, diffraction 
quality crystals of NoHAO were obtained at 20 °C from solution containing 8 μL of the as-isolated 
protein at 7.9 mg ml-1 in 20 mM Tris-HCl buffer, pH 7.5, and in a reservoir solution containing 2.6 M 
ammonium sulfate and 100 mM Na/K phosphate buffer (NaH2PO4/K2HPO4), pH 6.6. The crystals 
appeared within two days and grew to the size of 0.2  0.2  0.2 mm in 10 days. 
 
Data collection and structure analysis for NeHAO and NoHAO 
X-ray diffraction data were collected from a single crystal at the beamline AR-NW12A [41] 
of the Photon Factory (PF), High Energy Accelerator Research Organization, Tsukuba, Japan. A cryo-
protectant solution containing 30% trehalose, 2.6 M ammonium sulfate and 100 mM Na/K phosphate 
buffer pH 6.6 was gently added to the crystallization drop. The crystal was scooped up in a nylon 
CryoLoop™ (Hampton Research) and flash-cooled in a nitrogen-gas stream at 100 K.  No additional 
dehydration and/or annealing were performed. Diffraction data were collected with 1 s exposures for 
180° with 0.5° step oscillations over a total of 360 data points at a wavelength of 1.0 Å using Quantum 
210 CCD detector (Area Detector Systems Corp., Poway, CA, USA). Data were integrated and scaled 
using the program DENZO® and SCALEPACK from the HKL-2000® program suite [42]. The as-
isolated (apo) NoHAO crystals belonged to the space group I213 and one molecule existed in the 
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asymmetric unit with the solvent content of 81.88%.  
The structures of the as-isolated NeHAO and NoHAO in the apo-enzyme form were solved 
by the molecular replacement method using the previously reported NeHAO structure (Protein Data 
Bank ID code 4n4n) as a reference model by the program MOLREP [43]. Manual model building and 
molecular refinement were performed by using Coot [44] and Refmac5 within the CCP4 program suite 
[45–47]. The stereochemistry of the models was analyzed with the program Rampage [48]. Figures of 
the proteins were generated by PyMOL version 1.7.0.1, UCSF chimera package version 1.10.2 [49], 
Molecular Operating Environment (MOE) version 2015.1001 [50] and POV-Ray version 3.7.0 [51]. 
 
Results and discussion 
Mass culture systems for AOB strains.  
A large amount of AOB cell was required for inhibitor screening against live AOB and purification of 
HAO. Mass culture systems for AOB strains were reported only for Nitrosomonas europaea (NeAOB) 
and Nitrosococcus oceani (NoAOB). I have obtained six species of AOB strains that were deposited 
in public bioresource centers, and established mass culture systems for all the strains using modified 
culture medium and 20-L plastic carboy with air ventilation. The culture medium were modified by 
previously reported [35,37,52]. The yields of the wet cell pellets are about 1.5 g for each 20-L culture.  
 
High-throughput nitrification assay using live AOB cell 
Evaluation of activity of nitrification inhibitor candidates is important not only for in vitro enzyme 
assay level, but also for AOB live cell assay level. Many nitrification inhibitor assays have been 
performed for nitrification activity of AOB [13], but none of them could not be used for high-
throughput screening and evaluation as they are. The most commonly used assay method for the 
nitrification activity of AOB determines NO2
− concentration by a colorimetric assay using Griess 
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reagent, for which the absorbance is measured at 545 nm [38]. I optimized this method for high-
throughput screening and evaluation of nitrification inhibitors. In particular, the assay method was 
optimized for the 384-well microplate by re-profiling composition of the Griess reagent by referring 
to Giustarini et al. 2008 [38]. The detail conditions and procedures are described in Materials and 
Methods section. This method allows me to perform more than 3,000 assays within two days by 
manually.  
To assess my assay method quantitatively, I estimated a statistical parameter termed Z’-
factor that determines the suitability of an assay for high-throughput screening based on the signal 
dynamic range and the data variability [53]. A score of 1> Z’ ≥ 0.5 indicates an excellent assay, Z’ = 1 
an ideal assay, Z’ < 0 essentially impossible for screening. Calculated Z’-factors were 0.73 for the 
NeAOB assays, respectively, indicating that my method is suitable for high-throughput screening and 
inhibitor evaluation. Other validation statistics were summarized in Table 2. This method is considered 
to be suitable for screening to ~10,000 compounds class libraries and IC50 determination as a second 
screening to ~100 compounds.   
 
Table 2.  Validation statistics of nitrification inhibition assay for NeAOB on a 384-well 
microplate. 
Benchmark        Formula   NeAOB         
Coefficient value (CV %)a     =SD100%/Av100%
b ×100  3.8   
Signal Background ratio (S/B)    =Av100%/Av0%
c
   2.0   
Z’-factord             = 1 −  
3×SD100%+3×SD0%
Av100%−Av0%
 0.73   
an = 4. 
b545 nm absorbance measured at 30 min (without inhibitors). 
c545 nm absorbance measured at 0 min (without inhibitors). 
dReferred to Zhang et al. [53]. 
Purification of NeHAO and NoHAO by newly developed simplified methods 
I report new integrated purification methods for NeHAO and NoHAO. my methods only employ a 
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series of chromatography purification steps instead of cumbersome steps such as ammonium-
precipitation, buffer exchange, dilution and concentration used in the previously reported conventional 
methods [34,37,40,54,55]. Purification procedures and results for NeHAO and NoHAO are shown in 
Figure 6 and Figure 7, respectively. Purity of the HAOs eluted from gel-filtration column may be 
enough for enzymatic assay; hydroxyapatite and MonoQ column chromatography steps are optional 
to remove minor contaminations (Figure 6B and Figure 7B). The hydroxyapatite column step is not 
necessary for NoHAO. The purified proteins were identified as NeHAO and NoHAO using a protein 
sequencer (determined sequences are shown in Figure 27). Yields were 0.8 mg for NeHAO and 0.6 
mg for NoHAO from approximately 1.5 g of wet cell pellets. 
 Quality of the purified HAOs was analyzed by absorbance measurement (Figure 6D and 
Figure 7D). Judging from the 409/280 nm absorbance ratios of 3.39 and 3.94 respectively for the 
oxidized NeHAO and NoHAO, my purified proteins possess comparable or even higher purity than 
the corresponding proteins prepared by the conventional purification methods [22].  
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Figure 6. Integrated purification method for NeHAO. 
(A) Purification scheme of NeHAO. (B) Elusion profiles of HiTrap Q ion-
exchange, Superdex 200pg gel-filtration, CHT ceramic hydroxyapatite, 
and MonoQ ion-exchange chromatography of NeHAO. (C) SDS-PAGE 
analysis of HAO containing fractions at each chromatography steps of 
NeHAO. (D) UV-vis spectra for air-oxidized and dithionite reduced 
NeHAO.  
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Figure 7. Integrated purification method for NoHAO. 
(A) Purification scheme of NoHAO. (B) Elusion profiles of HiTrap Q ion-
exchange, Superdex 200pg gel-filtration, and MonoQ ion-exchange 
chromatography of NeHAO. (C) SDS-PAGE analysis of HAO containing 
fractions at each chromatography steps of NoHAO. (D) UV–vis spectra 
for air-oxidized and dithionite reduced NoHAO.  
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Optimization of middle-throughput HAO “COLORIMETRIC” assay 
Many activity assays and inhibitor assays have been performed for HAO [31,39,55], but none of them 
could not be used for screening and evaluation against a few hundred of compounds as they are. The 
most commonly used assay method is that the HAO activity is determined by monitoring the 
absorbance change at 550 nm due to the reduction of an electron acceptor cytochrome-c coupled with 
hydroxylamine oxidation by HAO [55]. I optimized this method for HAO inhibitor screening and 
evaluation. In particular, the assay method was optimized for the 384-well microplate assay by re-
profiling conditions of the buffer, pH, salt and additives. Figure 8A and B show that NeHAO and 
NoHAO displayed almost same pH-dependent activity profiles although the optimum pH values were 
slightly different, pH 9.4 for NeHAO and 10.0 for NoHAO. As an optimized buffer condition, I 
selected a pH 7.0, HEPES-NaOH buffer based upon the following reasons. (1) Since nitrous oxide 
produced during the hydroxylamine oxidation by HAO decreases pH of the assay solution, the HAO 
activity measured at an initial pH above 7.5 is too sensitive against pH decrease accompanied by 
hydroxylamine oxidation. (2) The activities at pH 7.0, 15% for both HAOs, are large enough for the 
inhibitor screening and evaluation. (3) The HAO activities measured at pH 7.0 in four different buffers 
were essentially the same. In addition, I used HEPES-NaOH buffer as the N. europaea culture medium. 
As an optimized salt concentration, I selected a 50 mM NaCl with which NeHAO and NoHAO 
displayed highest activities (Figure 8C and D). Furthermore, I confirmed that no significant changes 
in the NeHAO and NoHAO activities by addition of 0.5 % DMSO and 0.01% Triton X-100 (Figure 
8E). DMSO is frequently used as a solvent to dissolve chemicals in screening libraries, and Triton X-
100 is a detergent to prevent chemical aggregation of compounds and non-specific binding of enzymes 
to plastic wares [56]. Finally, measurements of the NeHAO and NoHAO reaction time courses under 
the optimized conditions allowed us to employ the activity value at 30 min for evaluating inhibitory 
response (Figure 8F). Calculated Z’-factors were 0.73 and 0.88 for the NeHAO and NoHAO assays, 
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respectively, indicating that the HAO colorimetric assay method is suitable for high-throughput 
screening and inhibitor evaluation. Other validation statistics were summarized in Table 3. This 
method is considered to be suitable for middle-throughput screening to ~1,000 compounds class 
libraries and IC50 determination as a second screening to ~100 compounds. On the other hand, the 
disadvantage of this assay method is using expensive horse cytochrome-c as a colorimetric probe 
(￥5,000/plate) and low sensitivity (S/B ~2). 
 
 
Figure 8. Optimization of HAO “COLORIMETRIC” assay using 
cytochrome-c. 
Effect of pH and buffer types for activity of NeHAO (A) and NoHAO (B). 
Effect of salt concentration for activity of NeHAO (C) and NoHAO (D). 
(E) Effect of additives (0.5 % DMSO and 0.01% Triton X-100) for 
activity of NeHAO and NoHAO. (F) Time courses of activity 
measurements for NeHAO and NoHAO. 
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Table 3. Validation statistics for HAO “COLORIMETRIC” assay using 
cytochrome-c on a 384-well microplate. 
 
Benchmark        Formula   NeHAO        NoHAO 
100% Average (Av100%)
a,b   -   0.72  0.82  
100% Standard deviation (SD100%)
 a,b  -   0.0275  0.0084  
Background Average (Av0%)
a,c  -   0.36  0.38 
Background Standard deviation (SD0%) 
a,c -   0.0057  0.0092 
Coefficient value (CV %)     =SD100%/Av100% ×100  3.79  1.02 
Signal Background ratio (S/B)    =Av100%/Av0%   2.01  2.17 
Z’-factord             = 1 −  
3×SD100%+3×SD0%
Av100%−Av0%
  0.73  0.88 
an = 4. 
b550 nm absorbance measured at 30 min (without inhibitors). 
c550 nm absorbance measured at 0 min (without inhibitors). 
dReferred to Zhang et al. [53]. 
 
 
Newly developed HAO “FLUORESCENCE” assay method 
The optimized HAO “COLORIMETRIC” assay enabled middle-throughput assay (~1000 assay/day), 
and is, however, high cost and low sensitivity method. So, I have newly developed high-throughput, 
high-sensitive, and low cost HAO fluorescence assay (resazurin method) applied to inhibitor screening 
and evaluation. All conventional HAO assays employ colorimetric probes (cytochrome-c, cytochrome 
c554, potassium ferricyanide, MTS {3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium}, etc.) whose absorbance was changed by accepting electron [31,39,55]. 
In contrast, the assay that I have developed uses fluorescence probe, resazurin, as an electron acceptor. 
The resazurin is changed to resorufin, strong fluorescence material, by accepting an electron (Figure 
9). The optimal wavelength of emission and excitation for resorufin was determined by 3D excitation-
emission map (Figure 10), and selected 562 nm for excitation wavelength and 592 nm for emission 
wavelength. I optimized this method for high-throughput and robust assay. In particular, the assay 
method was optimized for the 384-well microplate by profiling conditions of the incubation time, 
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buffer pH, and additives tolerance.  
Firstly, I optimized incubation time and buffer pH condition. The resorufin is changed to 
hydro-resorufin, fluorescence less material, by accepting one more electron (Figure 9). Controlling 
timing is critical to measure the fluorescence correctly. By profiling buffer conditions, fluorescence 
intensities of this method strongly dependent on the pH and buffer conditions (Figure 11A). This 
profile is different from HAO colorimetric assay which uses cytochrome-c as a probe (Figure 8A and 
B), and resorufin fluorescence itself (Figure 11B). The pH dependent fluorescence intensity change 
was caused by change of turn-over speed of resazurin reduced rate by HAO (Figure 11C). 
Fluorescence intensity was rapidly decreased by using optimum pH and buffer (e.g., pH5.5, Citrate-
phosphate buffer). Therefore, I selected pH 7.7, Tris-HCl buffer which provided a stable fluorescence 
signals for a long time (1~2 hours) (Figure 11C).  
Secondary, I optimized concentration of hydroxylamine (substrate). Fluorescence signal 
increased as raising the ratio of hydroxylamine/resazurin (Figure 12). In the ratio of 10, signal 
background ratio (S/B) is leaches 20, a very good value for screening.  Theoretically, concentration of 
the hydroxylamine is enough as one fourth as resazurin, because HAO generates four electrons from 
one hydroxylamine (Figure 3). HAO may transfer a greater part of the generated electrons to the 
oxygen dissolved in the solution. Therefore, I selected the condition of 500 μM hydroxylamine and 50 
μM resazurin (Figure 13). 
Thirdly, I checked tolerance of the assay against addition of 0.1% BSA, 0.03% Triton X-100 
(Figure 14), and several concentrations of DMSO (Figure 15). No significant signal change is 
detected by addition of the 0.1%BSA and 0.03%Triton-X. However, DMSO decreased the 
fluorescence signal of this assay significantly in a concentration dependent manner. Despite of 0.5% 
DMSO condition shows almost half S/B values (S/B = 10) compared with 0% DMSO condition (S/B 
= 23), the S/B value of 0.5% DMSO condition is enough for screening assay.  
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Calculated Z’-factor of this assay was 0.946 for NeHAO, indicating that the HAO 
fluorescence assay method is almost ideal for high-throughput screening and inhibitor evaluation. 
Other validation statistics were summarized in Table 4. 
Advantages of this HAO fluorescence assay method are summarized as follows : very low 
cost (<￥400/plate), high sensitivity (S/B ratio 5–23), good precision (CV value 0.8–2%), 
homogenous assay1 , hydroxylamine (substrate) and resazurin solutions can be stored in a freezer, 
effective pH range is wide as pH 5–7.3 (optimal pH value: pH5.8–6.0), whereas DMSO can be used 
concentration with less than 2%.  This method is considered to be suitable for screening to ~200,000 
compound class libraries and IC50 determination to ~1,000 compound class libraries. 
。  
Figure 9. Measurement principle of HAO fluorescence assay.  
(A) Fluorescence change of electronic states. (B) Time dependent 
fluorescence intensity change during HAO fluorescence assay.  
                                                   
1 Homogeneous assay: An assay formatted by a simple add, mix and read procedure without 
separation or washing steps [77]. 
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Figure 10. Excitation-emission profile for HAO fluorescence 
assay. 
3D excitation-emission graph (A) and normalized sliced graph (B).  The 
assay was performed by following conditions: 5 nM NeHAO, 1 mM 
NH2OH, 100 μM Resazurin, pH 7.5, 50 mM KPi buffer, 300 mM NaCl, 
assay volume 100 μL, incubate at ambient temperature (26 °C) for 2h, 
half bandwidth = 5 nm.  
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Figure 11. pH dependent fluorescent intensity difference for 
HAO fluorescence assay and resorufin. 
(A) HAO fluorescence assay. The assay condition is following: 150 mM NaCl, 
0.03 % Triton X-100, assay volume 100 μL, nonbinding 384-well black flat-
bottom plate, incubation at ambient temperature (26 °C) for 1h. (B) 
Commercially available resorufin, a reduced form of resazurin. (C) Time course 
of the HAO fluorescence assay. 
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Figure 12. Ratio of hydroxyalamine and resazurin affects signal 
background ratio on HAO fluorescence assay. 
Error bars represent standard deviations (n=3). 
 
 
 
Figure 13. Validation for HAO fluorescence assay. 
(A) Heat map of the validation assay that control assays performed for 
all wells on a 384-well plate. (B) Kinetics measurements for all the 384-
well assays with 30 sec intervals. (C) Intensity validations at 60 min 
values, which aligned A1 to B1 directions of 384-well plate. Validation 
statistics of this assay are shown in Table 4.  
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Figure 14. Additives check on HAO fluorescence assay. 
NeHAO 5 nM, pH 7.0, 50 mM KPi buffer, 150 mM KCl, ambient 
temperature (26 °C), 60 min, hydroxylamine 1 mM, resazurin 50 μM 
BSA, 0.03% Triton X-100. 
 
 
Figure 15. DMSO dependent activity of NeHAO fluorescence 
assay. 
(A) Signal intensities of NeHAO fluorescence assay on several DMSO 
concentrations. (B) Signal background ratio on several DMSO 
concentration. 5 nM NeHAO, 1 mM NH2OH, 100 μM resazurin, pH 7.0, 
50 mM KPi buffer, 150 mM NaCl, 0.03 % Triton X-100, incubate 60 min, 
ambient temperature (26 °C), total 100 μL volume, n=4, (0% ctrl: 
n=32), (1% DMSO = 141 mM) 
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Table 4. Validation statistics for HAO fluorescence assay using 
cytochrome-c on a 384-well microplate. 
Benchmark        Formula   NeHAO         
100% Average (Av100%)
a,b   -   32838    
100% Standard deviation (SD100%)
 a,b  -   534    
Background Average (Av0%)
c,d  -   1440   
Background Standard deviation (SD0%)
c,d -   31   
Coefficient value (CV %)     =SD100%/Av100%×100  2.16   
Signal Background ratio (S/B)    =Av100%/Av0%   22.8   
Signal Noise ratio (S/N)    = (Av100%-Av0%)/SD100% 1010   
Z’-factore              = 1 −  
3×SD100%+3×SD0%
Av100%−Av0%
  0.946   
an = 352. 
bRFU measured at 60 min (100% control wells). 
cn = 32. 
dRFU measured at 60 min (0% control wells). 
eReferred to Zhang et al. [53]. 
 
 
Structure analysis for NeHAO and NoHAO 
I solved crystal structures of the as-isolated (apo) NoHAO (Figure 16, new structure) and NeHAO 
(replication of previous report [32,33,57] ) at 2.6 Å and 2.2 Å resolutions, respectively. For the 
structure of NoHAO, I could continuously trace the electron density of 508 residues of the polypeptide 
starting at Asp30 which is consistent with my N-terminal sequence analysis for NoHAO (N-terminal 
sequence of NoHAO detected by protein sequencer was underlined in Figure 27).  
The γAOB NoHAO maintains structural features previously reported for the βAOB NeHAO 
[32,33,57]. The structure of NoHAO is described as a garlic-like shape composed of a homotrimer in 
which identical monomers are related by a crystallographic 3-fold axis (Figure 17 right). The subunits 
of NoHAO were linked by two covalent bonds between Tyr500 (Tyr491 in NeHAO) of one subunit 
and the active site heme P460 of an adjacent subunit as in NeHAO [33,34].  
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Figure 16. Crystals of NeHAO and NoHAO. 
Thin layered crystals of NeHAO (A) and cubic shaped crystals of NoHAO 
(B). The crystals of the HAOs showed red colored due to hemes which 
is cofactor of the HAOs. 
 
Figure 17. X-ray crystal structure of Nitrosococcus oceani HAO 
(NoHAO). 
Two views of the NoHAO trimer perpendicular view (left panel) and the 
3-fold symmetry axis view (right panel). The three monomers are 
shown in different colors. The three heme P460 and 21 heme-c groups 
are shown as stick models in red and pink, respectively. 
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Figure 18. Heme P460 in NoHAO was linked to the Tyrosine. 
(A) Close up view of the heme P460-Tyr500 two covalent bonds of the 
apo NoHAO. The mesh represents 2Fo-Fc electron density map 
contoured 1.0σ. (B) Chemical representation of the heme P460. Figures 
were prepared by PyMOL 1.7 (A) and MOE 2015.1001 (B). 
 
Conclusion 
I first established fundamental methods that required for nitrification inhibitor development study; 
integrated preparation systems for HAO, high-resolution three-dimensional structural information for 
NeHAO and NoHAO, high-throughput inhibition assay systems for live AOB cell (colorimetric) and 
purified HAO (colorimetric and fluorescence). 
Established sample preparation systems for HAOs are summarized in Table 5. AOB mass 
culture systems (~20 L) were successfully established for six deposited AOB strains. Five HAOs 
(except for N. lacus) including three new HAOs were successfully purified by my new purification 
systems. The crystal structures of two HAOs (N. europaea and N. oceani) were resolved successfully 
the crystal structures. Another two HAOs (N. sp JPCCT2 and N. multiformis) provided crystals but 
their crystallization conditions need to be optimized. Remaining one HAO (N. cryotolerans) is now 
under crystallization trial. 
Chapter 1 
Establishment of the experimental technology for nitrification inhibitor development 
44 
 
 
Table 5. Summary for sample preparation of HAOs. 
Description texts colored in red shows new results in this study. 
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Chapter 2 
Re-profiling for known nitrification 
inhibitors 
 
 
Introduction 
In this chapter, I have performed for re-profiling of known nitrification inhibitors. It has two reasons 
for performing re-profiling; 1) Revealing reference values of inhibition activity for newly developed 
nitrification inhibitor, 2) Search for the seed compounds for structure optimization for new nitrification 
inhibitor. 
In drug discovery project, it is required for designing new inhibitors that activity is stronger 
than the known inhibitors. As far as I know, 61 compounds, including 20 commercially available 
nitrification inhibitors, have been reported as nitrification inhibitors. Since inhibitory-activity of these 
nitrification inhibitors were examined by many different assay systems, such as field test and live AOB 
cell assay, etc., it is difficult to compare the reported activities directly. To overcome this difficulty and 
to determine the target value of inhibitory-activity for the newly developed nitrification inhibitors, I 
have purchased in-stock 38 compounds of known nitrification inhibitor (including 19 commercially 
available nitrification inhibitors registered in Japan and other countries) and performed re-profiling of 
theses known nitrification inhibitors using the standardized nitrification activity assay against live 
AOB cell (described in Chapter 1). This re-profiling results will be useful not only for determining 
target inhibitory-activity but also for discovery of seed compounds for nitrification inhibitor design 
[58,59]. 
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Materials and methods 
Nitrification activity assay 
NeAOB live cell culture was used for nitrification activity assay (illustrated in Figure 20). 
Nitrification activity assay including calculation of IC50 was performed by the method described in 
Chapter 1. 
 
Compounds  
 38 compounds of known nitrification inhibitors listed in Figure 20 were purchased from several 
chemical suppliers through the import company of Namiki Shoji (Tokyo, Japan).  
 
Results and discussion 
In this chapter, I have performed re-profiling of known nitrification inhibitors that were commercially 
available and reported in papers. I have collected 38 compounds, including 19 commercial nitrification 
inhibitors, that could be purchased from chemical suppliers. The compounds were analyzed for the 
inhibition activity (IC50) by using my optimized nitrification activity assay method against live AOB 
cells (described in Chapter 1). The compounds were assayed against NeAOB, which is the model 
species of AOB. The assay procedure was illustrated in Figure 19. The chemical list and the results 
are shown in Figure 20, and sorted graph was shown in Figure 21.  
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Figure 19. Nitrification activity assay procedure. 
 
 
The most effective inhibitors in all and in commercially available nitrification inhibitors are 
allylthiourea (IC50 = 0.4 μM) and thiourea (IC50 = 0.5 μM), respectively. However, allylthiourea has 
not been registered as a commercially available nitrification inhibitor due to the toxicity. Furthermore, 
thiourea has not been used in farm-land today due to the toxicity, as far as I know. Top four effective 
inhibitors are highly toxic compounds including thiourea analogs or a mercury compound (Figure 21). 
The most popular commercially available nitrification inhibitors of nitrapyrin, DMPP, and 
dicyandiamide showed IC50 of 1.8 μM, 4.1 μM, and about 400 μM, respectively. Therefore, the first 
target value of inhibitory-activity for the newly developed nitrification inhibitor has been set at IC50 = 
1.8 μM as same as that of nitrapyrin. 
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This re-profiling research also revealed the “weak effects” character for all of the assayed 
nitrification inhibitors. The most effective known nitrification inhibitor, allylthiourea, showed 
inhibitory-activity of IC50 = 0.4 μM only (Figure 20 compound No.23). Compared with an average 
IC50 value of 10 nM for commercially available medicines, the allylthiourea is 60 fold weaker than 
the average value of medicine. Additionally, it was revealed that nitrapyrin (Figure 20 compound 
No.3: developed by Dow agro), used in the United States mainly, and DMPP (Figure 20 compound 
No.1: developed by BASF), used in Europe, are not strongest inhibitors, and dicyandiamide (Figure 
20 compound No.2: commonly used generic agrochemical2), used in the Japan and other country, 
showed slight inhibition activity. 
These results are suggestive for the strategy and purpose for developing next generation 
nitrification inhibitors. Firstly, adaptation of medicinal drug discovery technique to nitrification 
inhibitor development will lead to production of new inhibitors which have medicine level inhibitory-
activity (IC50 ~10 nM). Secondary, structure development for which thiourea moieties used as seeds 
will lead to more effective nitrification inhibitor; in this case, of course, it is necessary to 
consider reducing toxicity. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                   
2 Generic agrochemical: Patent expired agrochemical. 
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Figure 20. Re-profiling for 38 known nitrification inhibitors. 
 
 
 
Chapter 2 
Re-profiling for known nitrification inhibitors 
50 
 
 
Figure 21. Sorted graph for IC50 of known nitrification inhibitors.
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Comparative analysis of inhibitor 
response and crystal structure for 
HAO 
 
Abstract 
I have observed distinct inhibitory responses of HAOs from beta-proteobacterial AOB (βAOB) 
Nitrosomonas europaea (NeHAO) and gamma-proteobacterial AOB (γAOB) Nitrosococcus oceani 
(NoHAO) against phenylhydrazine, a well-known suicide inhibitor for NeHAO. Consistently, the live 
cells of N. europaea, Nitrosomonas sp. JPCCT2 and Nitrosospira multiformis of βAOB displayed 
higher responses to phenylhydrazine than those of γAOB N. oceani. My crystal structure analysis and 
homology modeling studies suggest that different inhibitory responses of βAOB and γAOB are 
originated from different local environments around the substrate-binding sites of HAOs in these two 
classes of bacteria due to substitutions of two residues. The results reported herein strongly 
recommend inhibitor screenings against both NeHAO of βAOB and NoHAO of γAOB to develop 
HAO-targeting nitrification inhibitors with wide anti-AOB spectra. 
 
Introduction 
For developing nitrification inhibitors that possess wide anti-AOB spectra against a variety of 
uncultured soil AOB, proper model AOB strains must be selected. Okano et al. [14] showed that N. 
europaea is adequate to screening of nitrification inhibitors by using common nitrification inhibitors, 
including AMO-targeting inhibitor nitrapyrin, and βAOB strains. However, γAOB, which was 
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believed to inhabit only the sea and salt lake, has been detected in soil by metagenomic analysis, 
recently [60]. I thus need to determine which AOB strains are adequate to screening of HAO-targeting 
nitrification inhibitors. In addition, a simple but effective protein purification system and high-
throughput inhibitor screening/evaluation assay methods are also required to assess inhibitor response 
of HAO.  
Here, I show different inhibitor responses of HAOs from βAOB and γAOB by using 
optimized inhibitor evaluation systems including simplified HAO purification procedure and high-
throughput HAO activity assay. This results will assist developing effective nitrification inhibitors 
with wide anti-AOB spectra. 
 
Materials and methods 
Determine IC50 for nitrification activity of AOB cell 
Nitrification inhibition assays to determine IC50 of inhibitors were described in in Chapter 1.  
 
Determine IC50 for HAO inhibitor 
HAO inhibition assays to determine IC50 of inhibitors were used HAO colorimetric assay described in 
Chapter 1. 
 
Structure analysis for complexes of NoHAO-acetaldoxime and NoHAO-phenylhydrazine 
Crystallization, data collection and structure analysis for NoHAO were described in Chapter 1. 
Crystals of NoHAO in complex with acetaldoxime or phenylhydrazine were obtained by soaking the 
apo-enzyme crystals to reservoir solution including 1 M acetaldoxime or 10 mM phenylhydrazine 
within 1 min, and were performed data collection immediately. Successively, the NoHAO-
acetaldoxime and NoHAO-phenylhydrazine complex structures were solved by the molecular 
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replacement method using the resultant apo-enzyme form structure as the starting model. 
 
Homology modeling 
Homology modeling of βAOB Nitrosospira multiformis HAO (NmHAO) was performed using 
Molecular Operating Environment (MOE) software (version 2015.1001, Chemical Computing Group) 
with the following parameters: amino acid sequences of NmHAO (Uniprot: Q2YA36), template crystal 
structure of NeHAO (PDB:4n4n), induced fit includes hemes and a water molecule on the iron in heme 
P460, forcefield of Amber10:EHT. The graphical representations were prepared by PyMOL (version 
1.7.0.1, Schrodinger, LLC.). 
 
Results 
 
Comparison of inhibitory response between NeHAO of βAOB and NoHAO of γAOB 
NeHAO of βAOB and NoHAO of γAOB are characteristically different from each other in several 
points of views. NeHAO was purified as a complex with its partner protein NE1300 while NoHAO 
was purified as an isolated protein without any associate proteins (Figure 22A). As shown in Figure 
22B, the dithionite-reduced UV–vis spectra measured under the same conditions showed a marked 
difference of the heme P460 absorption peak positions between NeHAO (461.2 nm) and NoHAO 
(466.2 nm), suggesting different local environment around the substrate-binding sites of these two 
proteins as expected by my structure analysis study that showed different arrangements of the pocket-
forming residues between the βAOB HAO and γAOB HAO.  
These results suggested that HAO inhibitor responses are similar in the classes, but are different 
between the two classes. To verify this statement, I compared inhibitory responses of NeHAO and 
NoHAO, as representatives of βAOB and γAOB, to phenylhydrazine, a well-known NeHAO inhibitor 
(Figure 23A). Phenylhydrazine inhibited about 60% of the NeHAO activity at 10 μM while the 
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NoHAO activity was scarcely inhibited at the same concentration (Figure 23B). Consistently, the live 
cell assay showed higher phenylhydrazine response for βAOB, N. europaea, N. sp. JPCCT2 and N. 
multiformis, (IC50 = 0.9−1.2 μM) than γAOB N. oceani (2.9 μM) (Figure 23C). This difference is 
possibly caused by the difference of HAO structure between βAOB and γAOB. 
 
 
Figure 22. Comparison for SDS-PAGE and Uv–vis spectra of 
purified NeHAO and NoHAO. 
(A) SDS-PAGE analysis for concentrated NeHAO/NE1300 complex and 
NoHAO (each ~2 μg). (B) Comparison of UV–vis spectra around the 
heme P460 in NeHAO and NoHAO. The spectral data are the same as 
those of Figure 6D and Figure 7D heme-c peaks of the two proteins. 
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Figure 23. Difference of inhibitory responses of HAOs for 
phenylhydrazine. 
(A) Phenylhydrazine (PheHZN), an HAO specific inhibitor. (B) 
Determination of the half maximal inhibition centration (IC50) of 
phenylhydrazine against nitrification activity of live cells of three βAOB 
spices, Nitrosomonas europaea (NeAOB), Nitrosomonas sp. JPCCT2, 
Nitrosospira multiformis (NmAOB), and a γAOB spices, Nitrosococcus 
oceani (NoAOB). (C) Inhibition effects of phenylhydrazine against 
purified NeHAO from NeAOB (model of γAOB) and NoHAO from NoAOB 
(model of γAOB).  
 
 
 
Comparison of crystal structures of NeHAO and NoHAO 
The structures of NoHAO and NeHAO monomers could be superimposed to a rmsd of 0.79 Å for 499 
Cα-carbons (Figure 24C and D). This conservation is also applied to the homotrimeric structure and 
thus the positions of the 24 heme moieties arranged in a ring. In the previously reported crystal 
structures of the βAOB NeHAO, a physiological HAO partner protein NE1300 with unknown function 
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is present on the NeHAO molecular surface [33,34]. In contrast, no additional electron density for 
such associated protein(s) was observed for the γAOB NoHAO crystal (Chapter 1). It is noteworthy 
that NE1300 homologous genes are not found in the genome of N. oceani strain ATCC19707 used in 
this study. 
NoHAO has a γAOB HAO specific nine-amino-acid-long fragment, Thr220-Asp228, which 
is absent in the βAOB HAOs (Figure 27). This fragment is located at the edge of the substrate access 
channel on the molecular surface which is corresponding to the NE1300-binding site of the βAOB 
NeHAO (Figure 25). In fact, the γAOB HAO specific fragment of NoHAO occupies the same space 
as the NE1300 molecule in the NeHAO crystal structure when the HAO molecules are superimposed 
(Figure 24C). This observation suggests that the γAOB HAO specific fragment mimics a structural 
role of NE1300 in N. europaea to compensate the lack of the HAO partner protein. A similar structural 
role is also expected for the N1 domain (Gly38-Thr71, Figure 27) of the anammox HAO protein 
kustc1061 from Kuenenia Stuttgartiensis for which NE1300 homologous genes are not found in the 
genome. The N1 domain is apart from the enzyme core domain but occupies almost the same space as 
the γAOB HAO specific fragment of NoHAO and the NE1300 molecule in the NeHAO crystal 
(Figure 25). This difference between βAOB and γAOB may effect to the active center structure and 
its function. 
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Figure 24. Comparison of NeHAO and NoHAO. 
(A–B) Surface representation of NeHAO (PDB:4n4n, A) and NoHAO (B). 
(C) A superimposed main chain structures of NeHAO (blue) and NoHAO 
(grey) based on Cα-carbons. The γAOB fragment (T220–D228) of the 
NoHAO are shown in red. The superimpose calculation was performed 
by MOE. (D) A ring-like arrangements of hemes in trimeric structures 
of NoHAO (red: heme P460 and pink: heme-c) and NeHAO (blue). These 
hemes were superimposed by pair fitting on irons in each 24 hemes 
that the average rmsd value of the irons is 0.279 Å. The superimpose, 
pair fitting and figure preparations were performed by PyMOL. 
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Figure 25. Relative arrangement of entrance side of the ligand 
binding pocket on the NeHAO, NoHAO and Kustc1061. 
Surface representations of NeHAO with NE1300 (A), NoHAO (B) and 
Kustc1061 (C) are shown as side view (left) and clipped view around 
ligand binding pocket (right). (A) On NeHAO, small protein NE1300 
(green) is located to an entrance side of the ligand binding pocket. (B) 
On NoHAO, γAOB fragment (red) is located to the pocket side instead 
of the NE1300. (C) On Kustc1061, the N-terminal extension (brown) 
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elongated from the next subunit is located to the pocket side instead of 
the NE1300 or the γAOB fragment. Furthermore, pocket entrance on 
the Kustc1061 is very narrow due to the overhanging of the N-terminal 
extension (brown) and the C-terminal extension (grey). The figures 
were prepared PyMOL. 
 
 
Comparison of active center of HAOs 
A lot of uncultured ammonia-oxidizing bacteria (AOB) live in soil, and nitrification inhibitors should 
be effective to all of these AOB. Identity tree of HAO in isolated AOB (A) reflects classification of 
AOB, which are divided into two classes of beta-proteobacterial AOB (βAOB) and gamma-
proteobacterial AOB (γAOB), and βAOB are further divided into two families, Nitrosomonas and 
Nitrosospira, and γAOB includes one family, Nitrosococcus. We compared amino acid residues around 
the substrate binding pocket of HAO between βAOB and γAOB (Figure 26). Six residues arranged 
around the pocket on the catalytic heme P460 in the NeHAO crystal structure (Figure 26C) are 
completely conserved among three βAOB species (Figure 26B). Figure 26D shows that all of these 
six residues in the NmHAO model structure is nearly superimposable to those in the NeHAO crystal 
structure. On the other hand, sequence alignment and crystal structure revealed that two residues in 
γAOB (Phe367‒Asn368 in NoHAO) are varied from βAOB (Asn357‒Tyr358 in NeHAO). These results 
concluded that HAO inhibitor responses are similar in the classes, but are different between the two 
classes.  
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Figure 26. Comparison for active centers of NeHAO with other 
HAOs. 
(A) Identity tree for HAO from AOB species. (B) Multiple alignment for 
active-site residues in HAOs. Full-length sequence alignment is 
represented in Figure 27. (C) Overall structure and close-up view of 
the around active site of NeHAO (PDB:4n4n). Comparison of active-site 
residues in the NeHAO crystal structure with those in NmHAO modeled 
structure (D) and NoHAO crystal structure (E). “Wat” represents a water 
molecule that binds on the iron in heme P460. The identity tree was 
calculated by average distance clustering algorithm using identity of the 
full-length HAO alignment by using MOE software version 2015.1001 
(Chemical Computing Group Inc.). 
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Discussion 
In this chapter, I revealed the difference of inhibitory response between βAOB and γAOB by using 
inhibition assay for both of purified HAO and live AOB cell and structure analysis for NeHAO, 
NoHAO, and NmHAO. My studies clearly showed that βAOB are more sensitive to inhibition by 
phenylhydrazine than γAOB due to different local environments around the substrate-binding sites of 
HAOs in these two classes of bacteria. Different inhibitory responses between βAOB and γAOB may 
be emerged not only by phenylhydrazine but also by other inhibitors that bind to the active center in 
HAO. Even small difference in inhibitor sensitivity increases a risk for appearance of drug-resistant 
bacteria. The findings reported herein indicate that effects of inhibitors should be examined for at least 
two types of HAOs purified from βAOB and γAOB. Selection of NeHAO and NoHAO is the best 
choice for discovery of novel nitrification inhibitors targeting HAO with wide anti-AOB spectra due 
to the established purification and high-throughput screening methods and the long phylogenetically 
distance between N. europaea (NeAOB) of βAOB and N. oceani (NoAOB) of γAOB. 
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Figure 27 continues on next pages.  
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Figure 27 continued from previous page. 
 
Figure 27 continues on next page.  
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Figure 27 continued from previous page. 
 
Figure 27. Structure-guided multiple protein alignment of HAOs 
from AOB, comammox and anammox. 
 (A) Structure-guided multiple alignment of HAOs from several βAOB, 
γAOB, comammox and anammox bacteria. The alignment was performed 
by the two step approach. First, structure-based sequence alignment was 
performed for three proteins whose structures were solved; NeHAO 
(PDB: 4n4n), NoHAO (resolved by this study, PDB: not available), 
Kustc1061 (PDB: 4n4k). Second, sequence-only alignment was 
performed for all 12 proteins with constraints for the result of structure-
based alignment.  
    Protein identifiers and abbreviations represent on ahead of alignment. 
‘T’ on strain names, such as ATCC 19707T, shows type strains. The 
protein names belonged to βAOB, γAOB, comammox and anammox 
bacteria are printed in blue, green, red and brown, respectively. The 
protein names printed in bold are used for the structure-based 
alignment.  
The amino acid sequence printed in grey are N-terminal signal and 
C-terminal residues that disordered/calved in the crystal structures. The 
heme binding motif (CxxCH) for heme-c (heme 1–3 and 5–8) and heme 
P460 (heme4) are printed in red. Activating residues on heme P460 
defined by crystal structure are printed in green (the abbreviations of 
the residue number, Ne:NeHAO, No:NoHAO, Ku:Kustc1061). Inserted 
γAOB specific fragments are shown in red box. HAO loops includes the 
inserted fragments are shown in red dotted box. Active site walls are 
shown in blue dotted box.  
Figure 27 (legend) continues on next page.  
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Figure 27 (legend) continued from previous page. 
 
   Note that the side chain aromatic ring of the two residues (NeHAO: 
Y358, NoHAO: F367) are occupied roughly same spaces in the crystal 
structures, in spite of the position of the Cα-carbon and the alignment 
were shifted one residue.  
   The alignment calculations were performed by MOE. Pretty printing of 
the alignment was performed by BOXSHADE 3.21 server 
(http://www.ch.embnet.org/software/BOX_form.html). 
 
 (B) Sequence identity tree. The tree was calculated by average 
distance clustering algorithm using identity of the protein sequences. 
The calculation and graphical representation were performed by MOE 
version 2015.1001. 
 
(C) All-against-all pairwise identity matrix. The matrix values show 
identity percentages that were calculated by the following method; 
number of matched residues between sequences in row and column are 
divided by the length of sequence in the column. The calculation and 
graphical representation were performed by MOE. 
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Chapter 4 
HAO inhibitor screening  
Introduction 
In this chapter, I performed HAO inhibitor screening and structure development. It is very difficult to 
design inhibitors from scratch by using only a structure of an apo-enzyme of HAO. I first searched 
seed inhibitors which have low inhibition activity but bind to HAO active center by using soaking of 
HAO crystals. Then, I developed lead inhibitor candidates by using fragment-based drug (FBDD) 
design approach combined with large scale in-silico screening. 
 
Materials and methods 
Analysis for HAO-inhibitor complex structure 
Crystallization of NeHAO and NoHAO were described in Chapter 1. Data collection and structure 
analysis were described in Chapter 1.  
 
Docking model of HAO-benzaldoxime 
Docking model of HAO-benzaldoxime was prepared by energy minimization of molecular mechanism 
(MM) calculation using MOE 2014.10 software (Chemical Computer Group Inc.). The structure file 
of benzaldoxime was fetched from PubChem CID:5324611). For initial structure, benzaldoxime was 
arranged to NoHAO-acetaldoxime complex structure to overlap the hydroxylamine moiety (-N-OH) 
of each compounds. Then, energy minimization was performed for the initial structure using 
constraints with HAO and hydroxylamine moiety on the benzaldoxime. 
 
In-silico screening 
In-silico screening operations (conformation import and pharmacophore search) were performed using 
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Molecular Operating Environment (MOE) software (version 2015.1001, Chemical Computing Group) 
with the following parameters: database of Namiki shoji’s 5.6 million commercial compound catalog, 
pocket shape filter with NeHAO and NoHAO (PDB:4n4n), ligand temperate of pharmacophore feature 
of phenylhydrazine and acetaldoxime.  
 
Nitrification activity assay 
Nitrification activity assay including cell culture and calculation of IC50 was used the methods 
described in Chapter 1.  
 
Structure analysis for complex of NoHAO-benzaldoxime 
Crystallization, data collection and structure analysis for NoHAO were described in Chapter 1. 
Crystals of NoHAO in complex with benzaldoxime was obtained by soaking the apo-enzyme crystals 
to reservoir solution including 10 mM benzaldoxime within 1 min, and were performed data collection 
immediately. Successively, the NoHAO-benzaldoxime complex structure was solved by the molecular 
replacement method using the resultant apo-enzyme form structure as the starting model. 
 
Results and discussion 
Screening seed compounds by using crystal soaking and structure analysis 
I first screened seed compounds from 7 compounds including substrate mimics and known HAO 
inhibitors by using crystal soaking and structure analysis (Figure 28). Then, the two HAO-inhibitor 
complex structures were successfully solved for acetaldoxime, a non-commercial very weak 
nitrification inhibitor(CH3-CH2-O-NH) [61], and phenylhydrazine, a known HAO inhibitor 
(Phenyl-NH2-NH3) [31] (Figure 29).  
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Figure 28. Screening procedure for HAO inhibitor by crystal 
soaking and structure analysis. 
 
 
 
 Acetaldoxime and phenylhydrazine were located in a slightly different position on the heme 
P460, the active center in ligand bind pocket of NoHAO, in each crystal structures (Figure 29 A, B 
and C). The acetaldoxime binds to the Fe on the heme P460, and interacts to the conserved residues 
of Asp-301 and His-302 with mimicking substrate manner (Figure 29A and B). The phenylhydrazine 
binds to the entrance of the ligand binding pocket of NoHAO; the phenyl group of 
phenylhydrazine fits well into the hydrophobic patch on around the entrance (Figure 29C). 
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Figure 29. NoHAO-substrate mimic complex structures. 
Ligand binding pocket of NoHAO to which inhibitors bind (A). Close-up views 
of around heme P460 in ligand binding pocket of HAO-acetaldoxime (B) and 
HAO-phenylhydrazine (C) complex structures. 
 
 
 
Designing chimera compound by linking of two inhibitors by using fragment based drug 
design (FBDD) approach 
The two compounds, acetaldoxime and phenylhydrazine, were located in a slightly different position 
on the heme P460. Taking advantage of this feature, I applied a linking strategy of fragment-based 
drug design (FBDD) approach to design more potent compounds. This strategy allows me to design 
benzaldoxime which has the structure linking acetaldoxime with phenylhydrazine (Figure 30A).  By 
the docking simulation of benzaldoxime to NeHAO, benzaldoxime potentially binds on the heme P460 
in the active-center pocket of NeHAO. Fortunately, benzaldoxime was listed in the Namiki shoji’s 
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in-stock catalog library. To verify the utility of the FBDD approach, I purchased benzaldoxime and 
performed an HAO-benzaldoxime complex structure analysis. The NeHAO-benzaldoxime complex 
crystal structure was successfully solved (Figure 30B). The binding mode of benzaldoxime revealed 
by the experimental structure was very similar with that of the predicted docking model (Figure 30A 
and B). These results showed efficacy of the FBDD approach to develop inhibitors by using 
phenylhydrazine and acetaldoxime bound HAO structures as seeds information. Therefore, I have 
carried out designing new compounds using the FBDD approach combined with large scale in-silico 
screening techniques. 
 
 
Figure 30. Benzaldoxime designed by fragment-based drug 
design (FBDD) approach. 
(A) Benzaldoxime was designed by linking of two fragments 
(phenylhydrazine and acetaldoxime). (B) Crystal structure of NeHAO-
benzaldoxime complex. 
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FBDD approach combined with in-silico screening 
I carried out designing more effective inhibitors using FBDD approach combined with 
large-scale in-silico screening method featuring pharmacophore search. 
For preparation of the pharmacophore search, I have curated the commercial 
compound database catalog (3D structure of 5.3 million compounds) for drug screening 
provided by reagent vender of Namiki shoji (Tokyo, Japan). The library was washed 
(“Wash” is a MOE software command that executes ionizing and deleting salts), filtered 
(MOE command that selects drug-like compounds by using Lipinski’s rule of fives [62]), 
and executed conformation analysis (MOE command that search low energy 
conformations of the compounds) which are required for pharmacophore search. 
Pharmacophore search was performed for the drug-like focused library with conformational 
analysis. Firstly, the overlapped image of the two inhibitors are prepared on the MOE software 
2015.1001 (Figure 31B: superpose). Secondary, I set pharmacophore feature of aromatic ring (orange 
ball) on the phenyl ring of phenylhydrazine, hydrogen-bond donor (blue ball) on the oxygen, and 
hydrogen-bond donor/acceptor (pink ball) on the nitrogen of acetaldoxime (Figure 31B: Set 
pharmacophore). The pharmacophore represents steric and electronic features that is necessary to bind 
receptor. Thirdly, I set the pocket shape filter with NeHAO and NoHAO structure. This filters 
eliminated compounds that were larger than the pocket. Fourthly, I performed a search with the settings 
against commercially available 4.7 million compounds (Figure 31B: Search). In the results, I got 989 
hit compounds that had same pharmacophore features with combination of phenylhydrazine and 
acetaldoxime (Figure 31B: Hit 989 compounds). In other words, these hit compounds were predicted 
to bind HAO by same binding mode as the acetaldoxime and phenylhydrazine.  
Because the 989 compounds are too many perform assay, I selected 98 compounds from the 989 
compounds by using clustering of similar compound (by using MOE software 2015.1001) and manual 
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selection to select wide variety of compounds. Finally, I purchased 77 compounds which is in-stock 
compounds out of the 98 compounds. In the next chapter, I assayed these hit compounds by using 
high-throughput assay methods that I have developed.  
 
 
Figure 31. Scheme for in-silico screening combined with FBDD. 
(A) Whole scheme for in-silico screening. (B) Scheme focused on 
pharmacophore search.
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Appendix 
Integrated method for purification of 
Nitrosomonas europaea cytochrome c554, 
another potential target of nitrification 
inhibitor 
 
Abstract 
Cytochrome c554 is an electron transport protein involved in the nitrification pathway of Nitrosomonas 
europaea. A simplified production system for cytochrome c554 is required to reveal the functions of 
cytochrome c554, aiding efforts to control nitrification. Here, I described a novel purification method 
for N. europaea cytochrome c554 by utilizing a combination of HiTrap Q, HiTrap SP, Superdex 200, 
and Mono S columns. My method does not require the cumbersome and time-consuming steps 
associated with conventional purification methods, such as ammonia-sulfate fractionation and dialysis. 
This purification method allowed us to obtain highly pure cytochrome c554 in 2 days. This method is 
also adaptable for scale-up and/or automated purification to produce a large amount of protein. 
Therefore, my study provides an improved method for the purification of N. europaea cytochrome c554 
for applications that require a large amount of protein, such as crystal structure analysis and inhibitor 
screening. 
 
Introduction 
Cytochrome c554 from Nitrosomonas europaea (NeCyt c554) is a tetra-heme protein involved 
in its bacterial nitrification. NeCyt c554 is believed to act as a functional electron acceptor for NeHAO 
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[66] (Figure 3, Figure 40) and an electron donor for cytochromes c552 and cM552 [25,67]. Furthermore, 
NeCyt c554 may be directly involved in the emission of nitrous oxide (N2O), a powerful greenhouse 
gas. In low-oxygen conditions, cytochrome c554 may produce N2O by reducing NO generated from 
hydroxylamine by HAO [68,69] (Figure 40). However, the mechanism of this NeCyt c554 action is not 
fully understood. 
 
Figure 40. A simplified model of the nitrification pathway in 
Nitrosomonas europaea related with cytochrome c554.  
Ammonia monooxygenase (AMO) oxidizes ammonia (NH3) to 
hydroxylamine (NH2OH) using two electrons (e−). In the common 
pathway (black arrows), the hydroxylamine oxidoreductase (HAO) 
subsequently releases four electrons from one hydroxylamine coupled 
with the oxidization of hydroxylamine to nitrite (NO2−). The released 
electrons are then transferred to cytochrome c554. Half of the electrons 
are returned to AMO, and the remaining electrons are ultimately 
transferred to the terminal oxidases. In low-oxygen condition, a nitrous 
oxide (N2O)-forming pathway may be taken (grey arrows). Here, HAO 
generates nitric oxide (NO) from hydroxylamine, which is then 
converted to nitrous oxide (N2O) possibly by cytochrome c554. The N2O 
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pathway has not been fully characterized and alternative routes are 
believed to exist [27]. Some elements of the electron transfer pathway, 
such as the cytochrome c552 and cytochrome cM552, are not present in 
this model (for a detailed pathway, see Whittaker et al. [25]). 
 
The key components of the nitrification pathway are potential targets of nitrification 
inhibitors (See General introduction). AMO is the target of common commercial nitrification 
inhibitors such as nitrapyrin [28], and HAO has emerged as a new target for nitrification inhibitors 
[30,31]. Therefore, NeCyt c554 may also serve as a potential target in the development of novel 
nitrification inhibitors. 
NeCyt c554 is a 26-kDa protein that covalently interacts with four c-type hemes. Functional 
analysis and crystal structure studies of NeCyt c554 have been performed [70,71] using NeCyt c554 
purified by methods described by Yamanaka et al. [67] and Arciero et al. [72]. Development of 
inhibitors that target NeCyt c554 has not been reported. To develop NeCyt c554-specific inhibitors, a 
large amount of protein is needed for studies such as inhibitor screening or crystal structure analysis 
of the protein-inhibitor complex. Because a recombinant system for NeCyt c554 production has yet to 
be established, purification of native protein from AOB cells is required to produce NeCyt c554. 
However, current purification methods are associated with several cumbersome and time-consuming 
procedures, such as ammonia-sulfate fractionation and dialysis. 
In this study, I demonstrated a novel procedure for the purification of native cytochrome c554 
from N. europaea (NeAOB) strain NBRC 14298. The procedure encompassed optimized column types 
and conditions to obtain high purity product in a short period. This new procedure may be used to 
produce sufficient amounts of NeCyt c554 to accelerate its functional studies and the development of 
new nitrification inhibitors. 
 
Appendix  
Method development for future works 
90 
 
Materials and methods  
 
Purification of cytochrome c554 from NeAOB 
Cell line and cell culture method were described in Chapter 1. Frozen NeAOB cell pellet 
(1.5 g) was suspended in 40 mL buffer A (pH 7.5, 50 mM Tris-HCl) and sonicated. The suspension 
was then centrifuged at 40 000 × g for 40 min at 4 °C. Subsequently, the supernatant was applied to 
an anion-exchange column system composed of three tandemly connected HiTrap™ Q HP 5 mL 
columns (GE Healthcare, Buckinghamshire, England, UK), which were equilibrated with buffer A. A 
linear gradient of NaCl (illustrated in Figure 41A) was performed with 0–500 mM NaCl in 100 mL 
buffer A (this gradient elution step is not needed during a normal purification procedure). Post-elution 
cleaning was performed using 1 M NaCl. The flow-through fractions containing cytochrome c554 were 
then pooled and applied to a HiTrap™ SP HP 5 mL cation-exchange column (GE Healthcare) 
equilibrated with buffer A. Elution was performed by a linear NaCl gradient in buffer A (0–1 M, 100 
mL). Following elution, cleaning was performed using 1 M NaCl. The eluted cytochrome c554 fractions 
were subsequently applied to a HiLoad™ 26/600 Superdex™ 200 pg gel-filtration column (GE 
Healthcare) equilibrated with buffer B (pH 7.5, 10 mM Tris–HCl, 150 mM NaCl). Thereafter, the 
eluted cytochrome c554 fractions were applied to a high-performance cation-exchange column Mono 
S® 10/100 GL (GE Healthcare). The elution was performed using a linear gradient of NaCl in buffer 
A (0–1 M, 100 mL). The eluted cytochrome c554 fractions were then stored at 4 °C until further 
experiments. 
All chromatography procedures were performed using the ÄKTAexplore 100 system (GE 
Healthcare). All eluted fractions containing NeCyt c554 were detected by two methods: 1) wavelength 
monitoring by ÄKTAexplore (protein: 280 nm; c-type hemes in cytochrome c554: 409 nm) and 2) SDS-
PAGE analysis with Coomassie Brilliant Blue stain. The HiTrap Q column was regenerated by acid 
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acetone (80% acetone, 10% HCl, 10% water) to remove ingrained hemes after purification. The 
concentration of NeCyt c554 was determined by absorbance in the reduced form with ϵ554 = 24.6 mM
 
−1 cm−1 per heme [73]. 
 
Protein electrophoresis 
Tris-Glycine-SDS-PAGE was performed as described as Chapter 1. The sample buffer was also 
stocked in a −20 °C freezer in single-use volume because air oxidization of dithiothreitol led to 
diffusion of the NeCyt c554 band, as same as HAO.  
 
UV–vis spectroscopy 
The UV–vis spectra were measured from 220 to 800 nm with 0.2 nm bandwidth and 0.1 nm s−1 scan 
rate at 25 °C using Cary 400 Bio spectrophotometer (Varian, Zug, Switzerland). The measurement 
buffers were 10 mM Tris-HCl (pH 7.5), 150 mM NaCl with or without 50 mM dithionite. The 
dithionite was prepared as a 1 M solution, and was then added to the protein solution immediately 
before measurement. 
 
Mass spectrometry analysis 
Identification of the NeCyt c554 was performed by peptide mass fingerprinting using matrix 
assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS). The 
purified cytochrome c554, for which cysteine residues were not modified, was digested by L-
(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK)-treated trypsin (Thermo Fisher Scientific) 
for 18 hours at 37 °C in the Mono Q elution buffer condition. The digested peptide solution was mixed 
with a matrix solution composed of saturated α-cyano-4-hydroxycinnamic acid (Bruker Daltonics, 
Biellerica MA, USA) in 50:50:1 of water:acetonitrile:trifluoroacetic acid, spotted on a MALDI target 
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plate (MTP 384 massive; Bruker Daltonics), and dried at room temperature (25 °C). Acetonitrile and 
trifluoroacetic acid were purchased from Wako Pure Chemical Industries and Sigma-Aldrich, 
respectively. The mass spectrum was measured in a reflector-positive mode with a mass range of m/z 
200 to 3000 using an autoflex™ III smartbeam MALDI-TOF/MS instrument (Bruker Daltonics). 
Calibration was performed using the Peptide Calibration Standard (Bruker Daltonics). Data processing 
and peak assignments were performed using the mMass software version 5.5.0 [74]. Peptide mass 
fingerprinting search was performed by Mascot server (Matrix Science, Boston MA, USA) against the 
Swiss-Prot database using the default parameter. The assignment results were verified using the 
mMass software with the following parameters: the amino acid sequence of NeCyt c554 (UniprotKB 
entry C554_NITEU), one missed-cleavage of trypsin digestion, and a peptide mass tolerance of ±100 
ppm. 
 
Protein-Protein docking simulation 
Protein-protein docking simulation for NeHAO and NeCyt c554 was performed by ZDOCK 
server version 3.0.2 [75] with the crystal structure of NeHAO (PDB:4n4n) and NeCyt c554 
(PDB:1ft5). Graphical representations were performed by PyMOL 1.7. 
 
Results 
A new method for purifying native NeCyt c554 
In the present study, I reported an integrated purification method for native cytochrome c554 from N. 
europaea strain NBRC 14298 (NeCyt c554). My purification scheme (illustrated in Figure 41A) does 
not involve inconvenient steps associated with conventional purification procedures, such as 
ammonium-sulfate fractionation, dialysis, dilution, and concentration [67,72]. In the first 
chromatography step, 40 mL of cell lysate containing NeCyt c554 was passed through a HiTrap Q 
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column system (Figure 41B). Because NeCyt c554 showed a high pI value of 10.7 [67], the NeCyt c554 
was not adsorbed onto the anion-exchange column HiTrap Q. This step increased the purity of NeCyt 
c554 as assessed by SDS-PAGE (Figure 41F). In this study, I also demonstrated the effect of the HiTrap 
Q step through an additional NaCl-gradient elution. The elution profile clearly demonstrated that the 
HiTrap Q column was able to remove heme-containing proteins eluted at 115 mL (Figure 41G) and 
other non-heme contaminating proteins. This gradient elution is not necessary for normal NeCyt c554 
purification. In the second chromatography step, a HiTrap SP column was used to separate the NeCyt 
c554 (eluted at approximately 120 mL) from eluted contaminants in the flow-through and peak fractions 
eluted at 85 mL (Figure 41C). This HiTrap SP step was important to concentrate the NeCyt c554 in 
solution to be applied into the next gel-filtration column (HiLoad 26/600 Superdex 200 pg column) 
which has a maximum load-volume of 13 mL. In the third chromatography step using the Superdex 
200 column, NeCyt c554 was eluted at approximately 230–250 mL fractions and separated from 
contaminants and salt (Figure 41D). The gel-filtration column step was also important for the 
assessment and removal of aggregated proteins. Thus, no aggregated proteins were observed 
approximately the void-volume in this study. The final column step was performed using a high-
performance cation-exchange column Mono S for further purification and protein concentration 
(Figure 41E). In Mono S chromatography, NeCyt c554 was eluted as a single peak at 160 mL and no 
other contamination peaks were observed. The peak fractions showed red coloring. The protein yield 
was 0.4 mg from 20 L of NeAOB culture. 
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Figure 41. Purification scheme and elution profiles of 
chromatography for NeCyt c554. 
(A) Purification scheme for cytochrome c554 from NeAOB (NeCyt c554). 
(B) An anion-exchange chromatography using three tandemly 
connected HiTrap Q 5 ml columns. The flow-through fractions contained 
NeCyt c554. Peak A is a contamination peak that includes heme proteins. 
(C) A cation-exchange chromatography using a HiTrap SP 5 ml column. 
Elution was performed using 100 mL of NaCl linear gradient (0–1 M). 
(D) A gel-filtration chromatography using a HiLoad 26/600 Superdex 
Appendix  
Method development for future works 
95 
 
200 pg column. (E) A high performance cation-exchange 
chromatography using a Mono S 10/100 column. Elution was performed 
with 100 mL of NaCl linear gradient (0–1 M). NeCyt c554-containing 
fractions were detected by absorbance at 409 nm. (F) SDS-PAGE 
analysis of the NeCyt c554 during purification. The cell lysate and column 
elution fractions were analyzed by 15% SDS-PAGE. The cell lysate lane 
contained centrifuged supernatant fraction of sonicated cell lysates. 
Other lanes contained pooled fractions eluted from each column. Mono 
Q-eluted sample was concentrated and analyzed by SDS-PAGE in Fig 
3A. (G) SDS-PAGE analysis of the heme-containing peak (peak A) 
fraction on HiTrapQ chart (B) was compared with purified cytochrome 
c554 (purified Cyt c554). Cyt c554 may be found in the peak A fraction, but 
the amount was small. 
 
 
Characterization of the purified NeCyt c554 
The purified protein was analyzed by SDS-PAGE and observed as a single band of approximately 27 
kDa in size with high purity (Figure 42A). The apparent molecular mass was in agreement with the 
calculated molecular mass of 26.2 kDa for cytochrome c554 that includes four hemes. The purified 
protein was also identified as NeCyt c554 using a peptide mass fingerprinting through tryptic digestion 
and MALDI-TOF mass analysis (Figure 42B and C). Five peaks were assigned on the sequence of 
NeCyt c554. The sequence coverage and Mascot Search Results score were 18% and 64, respectively. 
I also evaluated the c-type hemes in NeCyt c554 by measuring the UV–vis spectra of the air-oxidized 
and dithionite-reduced status (Figure 42D). The spectra showed an absorption peak at 406 nm in the 
oxidized form and peaks at 419, 523.6, and 553.4 nm in the reduced form. These were in agreement 
with the previously reported spectra of NeCyt c554 showing an absorption peak at 407 nm in the 
oxidized form and peaks at 421, 524, and 554 nm in the reduced form [67]. Additionally, 430 nm 
shoulder on the Soret peak, a characteristic feature of NeCyt c554, was also observed in the spectrum 
of the oxidized form using the NeCyt c554 purified by my method. These spectral features demonstrated 
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that the purified protein was a mature NeCyt c554 containing c-type hemes. Purity of the protein was 
also verified using the spectrum of oxidized NeCyt c554. The absorbance ratio of 406 nm/280 nm 
(A406/A280) was 6.5. Given that Arciero et al. reported an A406/A280 value of 6.6 for NeCyt c554 [72], 
the cytochrome c554 purified using my method was highly pure and comparable to proteins prepared 
using conventional purification methods. These results indicated that my purification method can 
provide highly purified functional NeCyt c554 proteins using a much simpler procedure relative to the 
conventional methods. 
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Figure 42. Identification of purified NeCyt c554 protein. 
 (A) Purified and concentrated cytochrome c554 was analyzed by 15% 
SDS-PAGE with Coomassie Brilliant Blue stain using 0.9 μg of protein. 
The purified NeCyt c554 was observed as a single band at approximately 
27 kDa. (B) The MALDI-TOF mass spectrum of tryptic-digested purified 
NeCyt c554. (C) Assignment for the mass spectrum peaks. The matched 
peptides are underlined, and the “K148GQDFHFEER” was assigned as a 
peptide with one miss-cleavage in the C-terminal of Lys148. The 
truncated export-signal sequence is boxed, and the heme binding motifs 
(-CxxCH-) are highlighted in grey. The sequence coverage was 18%. 
(D) Assessment of heme in the purified NeCyt c554 by a UV–vis spectrum 
analysis. Air-oxidized cytochrome c554 (grey line) and cytochrome c554 
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reduced by 50 mM dithionite (black line) were represented in the 
spectra. The spectral scan was performed with a buffer composed of 10 
mM Tris-HCl (pH 7.5) and 150 mM NaCl at 25 °C. The protein 
concentration was 5 μM. The values on peak tops are wavelengths (nm) 
which were determined by the highest absorbance of a simple 3-point 
moving average. The inset provides a detailed view of the area around 
Q-band of the NeCyt c554. 
 
Docking simulation for NeHAO and NeCyt c554 
Protein-protein docking simulation was performed for NeHAO and NeCyt c554 (Figure 43). The model 
structure of the result showed that the NeCyt c554 binds to a valley on the interface of subunits of the 
NeHAO. The heme-c in NeHAO which located on the NeCyt c554-NeHAO binding surface is exposed 
to NeHAO surface. The heme-c in NeHAO is very close to a heme-c in NeCyt c554 (Figure 43).  Edge-
to-edge distance between the two hemes was 6.9 Å, which distance is capable for electron transfer 
from NeHAO to NeCyt c554 [76]. Therefore, the binding model is presented for the reliable prediction 
of interaction mode of NeCyt c554 with NeHAO. To design of protein-protein interaction inhibitors 
binding to the interaction surface will lead to new nitrification inhibitors which have novel mode of 
inhibitory-action. 
 
Figure 43. NeHAO-NeCyt c554 docking model. 
(A) Over all structure of NeHAO (red, blue green) and Cyt c554 (yellow) with 
hemes (wire model). (B) Arrangement of hemes in the complex. 
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Discussion 
Cytochrome c554 may directly be involved in the nitrification and N2O emission of AOB. 
My purification method will accelerate the study of NeCyt c554 mechanism, leading to the discovery 
of nitrification and N2O emission controlling technologies including nitrification inhibitors. Previously, 
a purification method for NeCyt c554 was described by Yamanaka, et al. [67] and its modification was 
described by Arciero, et al. [72], which were applied in several biochemical and structure analyses 
[54,70,71]. The method described by Arciero, et al. was simplified from the Yamanaka, et al method, 
yet it requires cumbersome procedures that involved the following steps: cell disruption by three 
freeze-thaw cycle, 80–90% ammonia-sulfate fractionation, hydrophobic interaction chromatography 
using Octyl-Sepharose, dialysis for desalting, cation-exchange chromatography using Amberlite CG-
50, and gel-filtration chromatography using Sephadex-G1000. These steps require a considerable 
amount of time, especially the ammonia-sulfate fractionation and dialysis steps, which take more than 
2 days and a day to complete, respectively. My method is simpler than these conventional methods. 
One major improvement was the removal of the ammonia-sulfate fractionation and dialysis steps. The 
column-operation procedure was also redesigned to take advantage of the pI value of 10.7 featured in 
NeCyt c554 [67]. In my method, a combination of flow-through into anion-exchange column and 
adsorption onto cation-exchange columns were utilized. Therefore, my method allowed for a complete 
purification within 2 days, including buffer preparation and column cleaning steps. 
Additionally, my purification method is readily applicable for scale-up and/or automated 
purification. Purified NeCyt c554 has been used not only for crystal structure and functional mechanism 
analyses [70,71], but also for colorimetric probe to measure the HAO activity [54]. Inconvenient 
purification method was a bottleneck for these studies that require a large amount of purified NeCyt 
c554. My purification method involved column operations only and no concentration, buffer exchange, 
and desalting steps were required. These features have allowed us to utilize a pilot-scale 
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chromatography system and/or an automated multistep chromatography system such as the 
ÄKTAxpress (GE Healthcare). Preparation of a large amount of NeCyt c554 enables us to perform 
inhibitor screening for NeCyt c554 and NeHAO binding inhibitors which bind to the protein-protein 
interaction surface. It will lead new paradigm of designing nitrification inhibitor.  
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